DANA-FARBER CANCER INSTITUTE: Form 990, tax year 2020

View the entire original 990 at ProPublica ↗

Organization: DANA-FARBER CANCER INSTITUTE (EIN 04-2263040)
Tax period: 2020-10-01 to 2021-09-30
Filed: 2022-07-29
IRS object ID: 202202109349301730
Schema version: 2020v4.1
Source: Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header
Form 990
Schedule A
Schedule B
Schedule C
Schedule D
Schedule F
Schedule G
Schedule H
Schedule I
Schedule J
Schedule K
Schedule K
Schedule L
Schedule M
Schedule O
Schedule R

Return header ReturnHeader

Field	Value	IRS element (for citing)
Return	2022-07-29T20:13:48-05:00	ReturnTs
Tax Period End	2021-09-30	TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

Preparer Firm Name PreparerFirmName

Field	Value	IRS element (for citing)
Business Name Line1	ERNST & YOUNG US LLP	BusinessNameLine1Txt

Preparer US Address PreparerUSAddress

Field	Value	IRS element (for citing)
Address Line1	200 CLARENDON STREET	AddressLine1Txt
City	BOSTON	CityNm
State Abbreviation	MA	StateAbbreviationCd
ZIP	021165072	ZIPCd

Field	Value	IRS element (for citing)
Return Type	990	ReturnTypeCd
Tax Period Begin	2020-10-01	TaxPeriodBeginDt

Filer Filer

Field	Value	IRS element (for citing)
EIN	042263040	EIN

Business Name BusinessName

Field	Value	IRS element (for citing)
Business Name Line1	Dana-Farber Cancer Institute Inc	BusinessNameLine1Txt

Field	Value	IRS element (for citing)
In Care Of	% MELISSA CHAMMAS	InCareOfNm
Business Name Control	DANA	BusinessNameControlTxt
Phone	6176323000	PhoneNum

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	450 Brookline Avenue BP418	AddressLine1Txt
City	Boston	CityNm
State Abbreviation	MA	StateAbbreviationCd
ZIP	02215	ZIPCd

Business Officer BusinessOfficerGrp

Field	Value	IRS element (for citing)
Person	MICHAEL L RENEY	PersonNm
Person Title	CFO & ASST TREASURER	PersonTitleTxt
Phone	6176326000	PhoneNum
Signature	2022-07-26	SignatureDt
Discuss With Paid Preparer	Yes (true)	DiscussWithPaidPreparerInd

Signing Officer SigningOfficerGrp

Person Full Name PersonFullName

Field	Value	IRS element (for citing)
Person First	MICHAEL L	PersonFirstNm
Person Last	RENEY	PersonLastNm

Field	Value	IRS element (for citing)
SSN	999009999	SSN

Preparer Person PreparerPersonGrp

Field	Value	IRS element (for citing)
Preparer Person	EMILY CINCOTTA	PreparerPersonNm
PTIN	P01272146	PTIN
Phone	6172662000	PhoneNum
Preparation	2022-07-24	PreparationDt

Additional Filer Information AdditionalFilerInformation

Trusted Customer TrustedCustomerGrp

Field	Value	IRS element (for citing)
Trusted Customer	2	TrustedCustomerCd

Field	Value	IRS element (for citing)
Tax	2020	TaxYr
Build TS	2022-09-23 18:48:47Z	BuildTS

Form 990 IRS990

Field	Value	IRS element (for citing)
Principal Officer	Laurie H Glimcher MD	PrincipalOfficerNm

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	450 BROOKLINE AVE	AddressLine1Txt
City	Boston	CityNm
State Abbreviation	MA	StateAbbreviationCd
ZIP	02215	ZIPCd

Field	Value	IRS element (for citing)
Gross Receipts	$2,419,108,987	GrossReceiptsAmt
Group Return For Affiliates	false	GroupReturnForAffiliatesInd
Organization501c3	Yes (X)	Organization501c3Ind
Website Address	www.dana-farber.org	WebsiteAddressTxt
Type Of Organization Corp	Yes (X)	TypeOfOrganizationCorpInd
Formation	1951	FormationYr
Legal Domicile State	MA	LegalDomicileStateCd
Activity Or Mission	SEE SCHEDULE O	ActivityOrMissionDesc
Voting Members Governing Body	61	VotingMembersGoverningBodyCnt
Voting Members Independent	60	VotingMembersIndependentCnt
Total Employee	6996	TotalEmployeeCnt
Total Volunteers	600	TotalVolunteersCnt
Total Gross UBI	$93,395	TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm	$21,930	NetUnrelatedBusTxblIncmAmt
PY Contributions Grants	$629,412,126	PYContributionsGrantsAmt
CY Contributions Grants	$726,297,460	CYContributionsGrantsAmt
PY Program Service Revenue	$1,310,450,921	PYProgramServiceRevenueAmt
CY Program Service Revenue	$1,571,455,891	CYProgramServiceRevenueAmt
PY Investment Income	$1,119,608	PYInvestmentIncomeAmt
CY Investment Income	$260,510	CYInvestmentIncomeAmt
PY Other Revenue	$64,222,756	PYOtherRevenueAmt
CY Other Revenue	$119,781,469	CYOtherRevenueAmt
PY Total Revenue	$2,005,205,411	PYTotalRevenueAmt
CY Total Revenue	$2,417,795,330	CYTotalRevenueAmt
PY Grants And Similar Paid	$3,795,934	PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid	$5,380,564	CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members	$0	PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members	$0	CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid	$660,439,151	PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid	$714,320,194	CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns	$2,561,617	PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns	$3,975,124	CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense	$40,626,637	CYTotalFundraisingExpenseAmt
PY Other Expenses	$1,302,561,710	PYOtherExpensesAmt
CY Other Expenses	$1,502,166,122	CYOtherExpensesAmt
PY Total Expenses	$1,969,358,412	PYTotalExpensesAmt
CY Total Expenses	$2,225,842,004	CYTotalExpensesAmt
PY Revenues Less Expenses	$35,846,999	PYRevenuesLessExpensesAmt
CY Revenues Less Expenses	$191,953,326	CYRevenuesLessExpensesAmt
Total Assets BOY	$3,905,849,954	TotalAssetsBOYAmt
Total Assets EOY	$4,549,977,055	TotalAssetsEOYAmt
Total Liabilities BOY	$1,750,598,738	TotalLiabilitiesBOYAmt
Total Liabilities EOY	$1,605,907,385	TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY	$2,155,251,216	NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY	$2,944,069,670	NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part III	Yes (X)	InfoInScheduleOPartIIIInd
Mission	SEE SCHEDULE O	MissionDesc
Significant New Program Srvc	false	SignificantNewProgramSrvcInd
Significant Change	false	SignificantChangeInd
Expense	$1,321,859,553	ExpenseAmt
Grant	$0	GrantAmt
Revenue	$1,571,455,891	RevenueAmt
Desc	Clinical Care - SEE SCHEDULE O	Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

Field	Value	IRS element (for citing)
Expense	$635,971,019	ExpenseAmt
Grant	$0	GrantAmt
Revenue	$0	RevenueAmt
Desc	Research - SEE SCHEDULE O	Desc

Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp

Field	Value	IRS element (for citing)
Expense	$31,728,016	ExpenseAmt
Grant	$5,380,564	GrantAmt
Revenue	$0	RevenueAmt
Desc	Community Benefits - SEE SCHEDULE O	Desc

Field	Value	IRS element (for citing)
Total Other Prog Srvc Expense	$0	TotalOtherProgSrvcExpenseAmt
Total Other Prog Srvc Grant	$0	TotalOtherProgSrvcGrantAmt
Total Other Prog Srvc Revenue	$0	TotalOtherProgSrvcRevenueAmt
Total Program Service Expenses	$1,989,558,588	TotalProgramServiceExpensesAmt
Described In Section501c3	Yes (true)	DescribedInSection501c3Ind
Schedule B Required	Yes (true)	ScheduleBRequiredInd
Political Campaign Acty	false	PoliticalCampaignActyInd
Lobbying Activities	Yes (true)	LobbyingActivitiesInd
Subject To Proxy Tax	false	SubjectToProxyTaxInd
Donor Advised Fund	false	DonorAdvisedFundInd
Conservation Easements	false	ConservationEasementsInd
Collections Of Art	false	CollectionsOfArtInd
Credit Counseling	false	CreditCounselingInd
Donor Rstr Or Quasi Endowments	Yes (true)	DonorRstrOrQuasiEndowmentsInd
Report Land Building Equipment	Yes (true)	ReportLandBuildingEquipmentInd
Report Investments Other Sec	false	ReportInvestmentsOtherSecInd
Report Program Related Invst	false	ReportProgramRelatedInvstInd
Report Other Assets	Yes (true)	ReportOtherAssetsInd
Report Other Liabilities	Yes (true)	ReportOtherLiabilitiesInd
Include FIN48 Footnote	false	IncludeFIN48FootnoteInd
Independent Audit Fincl Stmt	false	IndependentAuditFinclStmtInd
Consolidated Audit Fincl Stmt	Yes (true)	ConsolidatedAuditFinclStmtInd
School Operating	false	SchoolOperatingInd
Foreign Office	false	ForeignOfficeInd
Foreign Activities	Yes (true)	ForeignActivitiesInd
More Than5000 K To Org	false	MoreThan5000KToOrgInd
More Than5000 K To Individuals	false	MoreThan5000KToIndividualsInd
Professional Fundraising	Yes (true)	ProfessionalFundraisingInd
Fundraising Activities	Yes (true)	FundraisingActivitiesInd
Gaming Activities	false	GamingActivitiesInd
Operate Hospital	Yes (true)	OperateHospitalInd
Audited Financial Stmt Att	Yes (true)	AuditedFinancialStmtAttInd
Grants To Organizations	Yes (true)	GrantsToOrganizationsInd
Grants To Individuals	Yes (true)	GrantsToIndividualsInd
Schedule J Required	Yes (true)	ScheduleJRequiredInd
Tax Exempt Bonds	Yes (true)	TaxExemptBondsInd
Invest Tax Exempt Bonds	false	InvestTaxExemptBondsInd
Escrow Account	false	EscrowAccountInd
On Behalf Of Issuer	false	OnBehalfOfIssuerInd
Engaged In Excess Benefit Trans	false	EngagedInExcessBenefitTransInd
PY Excess Benefit Trans	false	PYExcessBenefitTransInd
Loan Outstanding	Yes (true)	LoanOutstandingInd
Grant To Related Person	false	GrantToRelatedPersonInd
Business Rln With Org Mem	false	BusinessRlnWithOrgMemInd
Business Rln With Fam Mem	false	BusinessRlnWithFamMemInd
Business Rln With35 Ctrl Ent	false	BusinessRlnWith35CtrlEntInd
Deductible Non Cash Contri	Yes (true)	DeductibleNonCashContriInd
Deductible Art Contribution	false	DeductibleArtContributionInd
Terminate Operations	false	TerminateOperationsInd
Partial Liquidation	false	PartialLiquidationInd
Disregarded Entity	Yes (true)	DisregardedEntityInd
Related Entity	Yes (true)	RelatedEntityInd
Related Organization Ctrl Ent	Yes (true)	RelatedOrganizationCtrlEntInd
Transaction With Control Ent	Yes (true)	TransactionWithControlEntInd
Trnsfr Exmpt Non Chrtbl Rltd Org	Yes (true)	TrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted Prtshp	false	ActivitiesConductedPrtshpInd
Schedule O Required	Yes (true)	ScheduleORequiredInd
IRP Document	634	IRPDocumentCnt
IRP Document W2 G	0	IRPDocumentW2GCnt
Backup Wthld Compliance	Yes (true)	BackupWthldComplianceInd
Employee	6996	EmployeeCnt
Employment Tax Returns Filed	Yes (true)	EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over Limit	Yes (true)	UnrelatedBusIncmOverLimitInd
Form990 T Filed	Yes (true)	Form990TFiledInd
Foreign Financial Account	Yes (true)	ForeignFinancialAccountInd
Foreign Country	CJ	ForeignCountryCd
Prohibited Tax Shelter Trans	false	ProhibitedTaxShelterTransInd
Taxable Party Notification	false	TaxablePartyNotificationInd
Nondeductible Contributions	false	NondeductibleContributionsInd
Quid Pro Quo Contributions	Yes (true)	QuidProQuoContributionsInd
Quid Pro Quo Contri Discl	Yes (true)	QuidProQuoContriDisclInd
Form8282 Property Disposed Of	false	Form8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft Cntrct	false	RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct	false	PayPremiumsPrsnlBnftCntrctInd
Indoor Tanning Services	false	IndoorTanningServicesInd
Subj To Tax Rmnrtn Ex Prcht Pymt	Yes (true)	SubjToTaxRmnrtnExPrchtPymtInd
Subject To Excs Tax Net Invst Inc	false	SubjectToExcsTaxNetInvstIncInd
Info In Schedule O Part VI	Yes (X)	InfoInScheduleOPartVIInd
Governing Body Voting Members	61	GoverningBodyVotingMembersCnt
Independent Voting Member	60	IndependentVotingMemberCnt
Family Or Business Rln	Yes (true)	FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties	false	DelegationOfMgmtDutiesInd
Change To Org Documents	false	ChangeToOrgDocumentsInd
Material Diversion Or Misuse	false	MaterialDiversionOrMisuseInd
Members Or Stockholders	false	MembersOrStockholdersInd
Election Of Board Members	false	ElectionOfBoardMembersInd
Decisions Subject To Approva	false	DecisionsSubjectToApprovaInd
Minutes Of Governing Body	Yes (true)	MinutesOfGoverningBodyInd
Minutes Of Committees	Yes (true)	MinutesOfCommitteesInd
Officer Mailing Address	false	OfficerMailingAddressInd
Local Chapters	false	LocalChaptersInd
Form990 Provided To Gvrn Body	Yes (true)	Form990ProvidedToGvrnBodyInd
Conflict Of Interest Policy	Yes (true)	ConflictOfInterestPolicyInd
Annual Disclosure Covered Prsn	Yes (true)	AnnualDisclosureCoveredPrsnInd
Regular Monitoring Enfrc	Yes (true)	RegularMonitoringEnfrcInd
Whistleblower Policy	Yes (true)	WhistleblowerPolicyInd
Document Retention Policy	Yes (true)	DocumentRetentionPolicyInd
Compensation Process CEO	Yes (true)	CompensationProcessCEOInd
Compensation Process Other	Yes (true)	CompensationProcessOtherInd
Investment In Joint Venture	false	InvestmentInJointVentureInd
States Where Copy Of Return Is Fld	AL	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	AK	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	AZ	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	CA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	CO	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	CT	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	DE	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	DC	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	FL	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	GA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	HI	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	ID	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	IL	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	IN	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	IA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	KS	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	KY	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	LA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	ME	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MD	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MI	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MN	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MS	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MO	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MT	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NE	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NV	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NH	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NJ	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NM	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NY	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NC	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	ND	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	OH	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	OK	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	OR	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	PA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	RI	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	SC	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	SD	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	TN	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	TX	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	UT	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	VT	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	VA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	WA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	WV	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	WI	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	WY	StatesWhereCopyOfReturnIsFldCd
Upon Request	Yes (X)	UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

Field	Value	IRS element (for citing)
Person	MELISSA CHAMMAS	PersonNm
Phone	6176326000	PhoneNum

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	450 BROOKLINE AVE BP418	AddressLine1Txt
City	Boston	CityNm
State Abbreviation	MA	StateAbbreviationCd
ZIP	02115	ZIPCd

Field	Value	IRS element (for citing)
Info In Schedule O Part VII	Yes (X)	InfoInScheduleOPartVIIInd

Form990 Part VII Section A Form990PartVIISectionAGrp (86 entries)

TitleTitleTxt	Average Hours Per WeekAverageHoursPerWeekRt	Average Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRt	Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd	OfficerOfficerInd	Reportable Comp From OrgReportableCompFromOrgAmt	Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt	Other CompensationOtherCompensationAmt	Highest Compensated EmployeeHighestCompensatedEmployeeInd	Key EmployeeKeyEmployeeInd	Former Ofcr Director TrusteeFormerOfcrDirectorTrusteeInd
Glimcher Laurie H MD
Trustee, President and CEO	44.0	6.0	Yes (X)	Yes (X)	$1,724,225	$0	$302,393
Benz Edward J JR MD
President and CEO Emeritus	50.0	0.0			$1,133,382	$0	$57,427	Yes (X)
Reney Michael L
CFO and Asst. Treasurer	46.0	4.0		Yes (X)	$829,041	$0	$43,894
Hahn William MD PHD
COO & EVP	50.0	0.0		Yes (X)	$799,032	$0	$43,460
Terwilliger James
FORMER COO & EVP	48.0	2.0			$815,197	$0	$24,858	Yes (X)
Bunnell Craig A MD
CHIEF MEDICAL OFFICER	50.0	0.0			$776,215	$0	$46,443		Yes (X)
Winer Eric MD
Chief of Div of WMNS CANCERS	50.0	0.0			$760,184	$0	$54,768	Yes (X)
Soiffer Robert MD
Chief of Hemotologic Malig.	50.0	0.0			$722,519	$0	$59,949	Yes (X)
DUVAL MELANY
SVP OF DEVELOPMENT	50.0	0.0			$697,803	$0	$73,719		Yes (X)
Constantine Michael MD
Milford Med Dir-Hematol Onc	50.0	0.0			$700,983	$0	$61,137	Yes (X)
Johnson Bruce MD
CHIEF CL RES OFF(END 9/1/21)	50.0	0.0			$679,531	$0	$61,539		Yes (X)
Boskey Richard S ESQ
ASST. SEC. & GC (END 12/14/20)	45.0	5.0		Yes (X)	$652,019	$0	$68,313
Griffin James D MD
PROFESSOR OF MEDICINE	50.0	0.0			$642,164	$0	$65,398			Yes (X)
Rollins Barrett J MD PHD
SNR ADVISOR TO PRESIDENT & CEO	50.0	0.0			$590,875	$0	$60,481		Yes (X)
Megdal Maria
SVP of Institute Operations	50.0	0.0			$527,540	$0	$58,592		Yes (X)
Stone Richard M MD
PROFESSOR OF MEDICINE	50.0	0.0			$494,776	$0	$68,441			Yes (X)
Liebow Elizabeth
CHIEF STRATEGY OFFICER	50.0	0.0			$464,291	$0	$66,047			Yes (X)
Memmott Drew
SVP RESEARCH ADMINISTRATION	50.0	0.0			$464,783	$0	$63,038			Yes (X)
Meyerhardt Jeffrey
CHIEF CL RES OFF(as of 9/1/21)	50.0	0.0			$428,226	$0	$73,601		Yes (X)
Haigis Kevin
Chief Scientific Officer	50.0	0.0			$459,668	$0	$3,588		Yes (X)
Gettleman Wendy
VP of Facilities MGMT & RE	50.0	0.0			$348,087	$0	$65,137		Yes (X)
Bartel Sylvia RPH MHP
VP of Pharmacy Services	50.0	0.0			$327,046	$0	$64,942		Yes (X)
Ebert Benjamin MD PHD
Chair of Medical Oncology	50.0	0.0			$200,400	$0	$8,311		Yes (X)
Ryan John
Asst Sec. & GC(as of 12/14/20)	45.0	5.0		Yes (X)	$80,838	$0	$2,016
ALEXANDER SUSAN ESQ
Trustee	1.0	0.0	Yes (X)		$0	$0	$0
Bekenstein Joshua
Trustee & Chairman	2.0	0.0	Yes (X)	Yes (X)	$0	$0	$0
BERGER HARVEY MD
Trustee	1.0	0.0	Yes (X)		$0	$0	$0
Berkowitz Roger
Trustee	1.0	0.0	Yes (X)		$0	$0	$0
Berylson Amy
Trustee	1.0	0.0	Yes (X)		$0	$0	$0
Beschloss Afsaneh
Trustee	1.0	0.0	Yes (X)		$0	$0	$0
Blum Betty Ann
Trustee	1.0	0.0	Yes (X)		$0	$0	$0
Brock-Wilson Jane
Trustee	1.0	0.0	Yes (X)		$0	$0	$0
Chandra Monica
Trustee & Secretary	2.0	0.0	Yes (X)	Yes (X)	$0	$0	$0
Cohen Timothy
Trustee	1.0	0.0	Yes (X)		$0	$0	$0
DALEY KAREN PHD MPH RN FANN
Trustee	1.0	0.0	Yes (X)		$0	$0	$0
DaSilva Kevin
Trustee	1.0	0.0	Yes (X)		$0	$0	$0
Eisenson Michael
Trustee (As of 2/3/21)	1.0	0.0	Yes (X)		$0	$0	$0
Fine Stephen
Trustee	1.0	0.0	Yes (X)		$0	$0	$0
Forbes Moira
Trustee (As of 2/3/21)	1.0	0.0	Yes (X)		$0	$0	$0
Gibson Nancy
Trustee	1.0	0.0	Yes (X)		$0	$0	$0
Greenthal Jill
Trustee	1.0	0.0	Yes (X)		$0	$0	$0
Gross Phillip
Trustee	1.0	0.0	Yes (X)		$0	$0	$0
Hadley Christopher
Trustee	1.0	0.0	Yes (X)		$0	$0	$0
Jaffe Alison
Trustee	1.0	0.0	Yes (X)		$0	$0	$0
Jamieson Jane
Trustee	1.0	0.0	Yes (X)		$0	$0	$0
Janower Andrew
Trustee	1.0	0.0	Yes (X)		$0	$0	$0
KAPLAN ANDREW
Trustee	1.0	0.0	Yes (X)		$0	$0	$0
Knez Brian
Trustee	1.0	0.0	Yes (X)		$0	$0	$0
Koppel Steven
Trustee	1.0	0.0	Yes (X)		$0	$0	$0
KOSTER STEPHEN ESQ
Trustee	1.0	0.0	Yes (X)		$0	$0	$0
KYLE AMY ESQ
Trustee	1.0	0.0	Yes (X)		$0	$0	$0
Lotane Nancy
Trustee	1.0	0.0	Yes (X)		$0	$0	$0
Lubin Richard
Trustee & Vice-Chairman	2.0	0.0	Yes (X)	Yes (X)	$0	$0	$0
Lucas Bradley
Trustee	1.0	0.0	Yes (X)		$0	$0	$0
Lucchino Lawrence
Trustee (Term ended 2/3/21)	1.0	0.0	Yes (X)		$0	$0	$0
Marcus Paul
Trustee	1.0	0.0	Yes (X)		$0	$0	$0
Martin Demond
Trustee	1.0	0.0	Yes (X)		$0	$0	$0
MCCAIN TRACEY ESQ
Trustee	1.0	0.0	Yes (X)		$0	$0	$0
McCann James
Trustee (As of 2/3/21)	1.0	0.0	Yes (X)		$0	$0	$0
MEDEL ROGER MD
Trustee	1.0	0.0	Yes (X)		$0	$0	$0
MILLER ERIC PHD
Trustee	1.0	0.0	Yes (X)		$0	$0	$0
Norberg Joseph
Trustee	1.0	0.0	Yes (X)		$0	$0	$0
O'Connor John
TRUSTEE & Treasurer	2.0	0.0	Yes (X)	Yes (X)	$0	$0	$0
Packman Karen Linde
Trustee	1.0	0.0	Yes (X)		$0	$0	$0
Palandjian Peter
Trustee	1.0	0.0	Yes (X)		$0	$0	$0
Pasquarello Theodore
Trustee	1.0	0.0	Yes (X)		$0	$0	$0
Penrose Fatima
Trustee	1.0	0.0	Yes (X)		$0	$0	$0
Perini Jennifer
Trustee	1.0	0.0	Yes (X)		$0	$0	$0
PERLMUTTER STEVEN ESQ
Trustee (Term Ended 5/24/21)	1.0	0.0	Yes (X)		$0	$0	$0
Poduska Susan
Trustee	1.0	0.0	Yes (X)		$0	$0	$0
Reynolds Robert
Trustee	1.0	0.0	Yes (X)		$0	$0	$0
SACHS ROBERT ESQ
Trustee	1.0	0.0	Yes (X)		$0	$0	$0
Schlager Eric
Trustee	1.0	0.0	Yes (X)		$0	$0	$0
Sen Laura
Trustee	1.0	0.0	Yes (X)		$0	$0	$0
Stansky Robert
Trustee	1.0	0.0	Yes (X)		$0	$0	$0
STRATFORD SANDRA MD MSC
TRUSTEE	1.0	0.0	Yes (X)		$0	$0	$0
Stecher Esta
Trustee	1.0	0.0	Yes (X)		$0	$0	$0
Sullivan Ronald
Trustee	1.0	0.0	Yes (X)		$0	$0	$0
Svanberg Louise
Trustee	1.0	0.0	Yes (X)		$0	$0	$0
Terrana Beth
Trustee	1.0	0.0	Yes (X)		$0	$0	$0
Tocio Mary Ann
Trustee	1.0	0.0	Yes (X)		$0	$0	$0
Trotsky Michael
Trustee	1.0	0.0	Yes (X)		$0	$0	$0
TULI SUSHIL
Trustee	1.0	0.0	Yes (X)		$0	$0	$0
Walker Jodi
Trustee	1.0	0.0	Yes (X)		$0	$0	$0
Whelan Lori
Trustee	1.0	0.0	Yes (X)		$0	$0	$0
Williams Frederica
Trustee	1.0	0.0	Yes (X)		$0	$0	$0

Field	Value	IRS element (for citing)
Total Reportable Comp From Org	$15,318,825	TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org	$0	TotReportableCompRltdOrgAmt
Total Other Compensation	$1,497,492	TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K	1673	IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed	Yes (true)	FormerOfcrEmployeesListedInd
Total Comp Greater Than150 K	Yes (true)	TotalCompGreaterThan150KInd
Compensation From Other Srcs	false	CompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (5 entries)

Address Line1ContractorAddress/USAddress/AddressLine1Txt	CityContractorAddress/USAddress/CityNm	State AbbreviationContractorAddress/USAddress/StateAbbreviationCd	ZIPContractorAddress/USAddress/ZIPCd	ServicesServicesDesc	CompensationCompensationAmt
Mass General Brigham INC
399 Revolution Drive Ste 645	SOMERVILLE	MA	02145	INFORMATION SYS	$91,011,252
BRIGHAM AND WOMEN'S HOSPITAL
399 Revolution Drive Ste 645	SOMERVILLE	MA	02145	MEDICAL SERVICES	$76,953,920
WALSH BROTHERS INC
200 Commercial Street	BOSTON	MA	02190	BUILDING CONTRACTOR	$50,485,417
Cardinal Health
736 Cambridge Street	BRIGHTON	MA	02135	MEDICAL SERVICES	$39,036,057
BRIGHAM AND WOMEN'S PHYSICIANS ORG
75 Francis Street	BOSTON	MA	02115	MEDICAL SERVICES	$15,144,180

Field	Value	IRS element (for citing)
Cntrct Rcvd Greater Than100 K	524	CntrctRcvdGreaterThan100KCnt
Federated Campaigns	$200,807	FederatedCampaignsAmt
Fundraising	$15,599,692	FundraisingAmt
Government Grants	$207,559,702	GovernmentGrantsAmt
All Other Contributions	$502,937,259	AllOtherContributionsAmt
Noncash Contributions	$20,527,341	NoncashContributionsAmt
Total Contributions	$726,297,460	TotalContributionsAmt

Program Service Revenue ProgramServiceRevenueGrp (3 entries)

DescDesc	BusinessBusinessCd	Total Revenue ColumnTotalRevenueColumnAmt	Related Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmt
NET PATIENT SERVICE REVENUE	621110	$1,564,202,278	$1,564,202,278
NETWORK COLLABORATION	900099	$6,388,781	$6,388,781
LINAC	621500	$864,832	$864,832

Field	Value	IRS element (for citing)
Total Program Service Revenue	$1,571,455,891	TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$120,197	TotalRevenueColumnAmt
Exclusion	$120,197	ExclusionAmt

Incm From Invest Bond Proceeds IncmFromInvestBondProceedsGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$0	TotalRevenueColumnAmt

Royalties Revenue RoyaltiesRevenueGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$111,088,013	TotalRevenueColumnAmt
Exclusion	$111,088,013	ExclusionAmt

Gross Rents GrossRentsGrp

Field	Value	IRS element (for citing)
Real	$2,207,493	RealAmt

Rental Income Or Loss RentalIncomeOrLossGrp

Field	Value	IRS element (for citing)
Real	$2,207,493	RealAmt
Personal	$0	PersonalAmt

Net Rental Income Or Loss NetRentalIncomeOrLossGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$2,207,493	TotalRevenueColumnAmt
Exclusion	$2,207,493	ExclusionAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

Field	Value	IRS element (for citing)
Other	$140,313	OtherAmt

Gain Or Loss GainOrLossGrp

Field	Value	IRS element (for citing)
Other	$140,313	OtherAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$140,313	TotalRevenueColumnAmt
Exclusion	$140,313	ExclusionAmt

Field	Value	IRS element (for citing)
Fundraising Gross Income	$256,368	FundraisingGrossIncomeAmt
Contri Rpt Fundraising Event	$15,599,692	ContriRptFundraisingEventAmt
Fundraising Direct Expenses	$1,313,657	FundraisingDirectExpensesAmt

Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp

Field	Value	IRS element (for citing)
Total Revenue Column	-$1,057,289	TotalRevenueColumnAmt
Exclusion	-$1,057,289	ExclusionAmt

Field	Value	IRS element (for citing)
Gaming Gross Income	$0	GamingGrossIncomeAmt
Gaming Direct Expenses	$0	GamingDirectExpensesAmt

Net Income From Gaming NetIncomeFromGamingGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$0	TotalRevenueColumnAmt

Field	Value	IRS element (for citing)
Gross Sales Of Inventory	$0	GrossSalesOfInventoryAmt
Cost Of Goods Sold	$0	CostOfGoodsSoldAmt

Net Income Or Loss NetIncomeOrLossGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$0	TotalRevenueColumnAmt

Other Revenue Misc OtherRevenueMiscGrp (3 entries)

DescDesc	BusinessBusinessCd	Total Revenue ColumnTotalRevenueColumnAmt	ExclusionExclusionAmt
PARKING LOT REVENUE	812930	$3,167,144	$3,167,144
FOOD SERVICE REVENUE	722210	$2,516,332	$2,516,332
WCB BOUTIQUE REVENUE	446199	$698,598	$698,598

Miscellaneous Revenue MiscellaneousRevenueGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$1,161,178	TotalRevenueColumnAmt
Unrelated Business Revenue	$93,395	UnrelatedBusinessRevenueAmt
Exclusion	$1,067,783	ExclusionAmt

Field	Value	IRS element (for citing)
Other Revenue Total	$7,543,252	OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$2,417,795,330	TotalRevenueColumnAmt
Related Or Exempt Func Income	$1,571,455,891	RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue	$93,395	UnrelatedBusinessRevenueAmt
Exclusion	$119,948,584	ExclusionAmt

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

Field	Value	IRS element (for citing)
Total	$3,339,220	TotalAmt
Program Services	$3,339,220	ProgramServicesAmt

Grants To Domestic Individuals GrantsToDomesticIndividualsGrp

Field	Value	IRS element (for citing)
Total	$2,041,344	TotalAmt
Program Services	$2,041,344	ProgramServicesAmt

Foreign Grants ForeignGrantsGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Benefits To Members BenefitsToMembersGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

Field	Value	IRS element (for citing)
Total	$9,120,546	TotalAmt
Program Services	$3,461,961	ProgramServicesAmt
Management And General	$4,960,782	ManagementAndGeneralAmt
Fundraising	$697,803	FundraisingAmt

Comp Disqual Persons CompDisqualPersonsGrp

Field	Value	IRS element (for citing)
Total	$4,014,593	TotalAmt
Program Services	$1,601,231	ProgramServicesAmt
Management And General	$2,413,362	ManagementAndGeneralAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

Field	Value	IRS element (for citing)
Total	$573,990,840	TotalAmt
Program Services	$482,976,987	ProgramServicesAmt
Management And General	$65,563,006	ManagementAndGeneralAmt
Fundraising	$25,450,847	FundraisingAmt

Pension Plan Contributions PensionPlanContributionsGrp

Field	Value	IRS element (for citing)
Total	$24,960,752	TotalAmt
Program Services	$19,038,502	ProgramServicesAmt
Management And General	$4,800,037	ManagementAndGeneralAmt
Fundraising	$1,122,213	FundraisingAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

Field	Value	IRS element (for citing)
Total	$62,291,802	TotalAmt
Program Services	$47,512,293	ProgramServicesAmt
Management And General	$11,978,925	ManagementAndGeneralAmt
Fundraising	$2,800,584	FundraisingAmt

Payroll Taxes PayrollTaxesGrp

Field	Value	IRS element (for citing)
Total	$39,941,661	TotalAmt
Program Services	$30,465,004	ProgramServicesAmt
Management And General	$7,680,915	ManagementAndGeneralAmt
Fundraising	$1,795,742	FundraisingAmt

Fees For Services Management FeesForServicesManagementGrp

Field	Value	IRS element (for citing)
Total	$6,746,026	TotalAmt
Program Services	$5,806,405	ProgramServicesAmt
Management And General	$939,621	ManagementAndGeneralAmt

Fees For Services Legal FeesForServicesLegalGrp

Field	Value	IRS element (for citing)
Total	$19,615,445	TotalAmt
Program Services	$13,880,237	ProgramServicesAmt
Management And General	$5,650,892	ManagementAndGeneralAmt
Fundraising	$84,316	FundraisingAmt

Fees For Services Accounting FeesForServicesAccountingGrp

Field	Value	IRS element (for citing)
Total	$758,556	TotalAmt
Management And General	$758,556	ManagementAndGeneralAmt

Fees For Services Lobbying FeesForServicesLobbyingGrp

Field	Value	IRS element (for citing)
Total	$531,835	TotalAmt
Program Services	$531,835	ProgramServicesAmt

Fees For Services Prof Fundraising FeesForServicesProfFundraising

Field	Value	IRS element (for citing)
Total	$3,975,124	TotalAmt
Fundraising	$3,975,124	FundraisingAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Fees For Services Other FeesForServicesOtherGrp

Field	Value	IRS element (for citing)
Total	$207,634,923	TotalAmt
Program Services	$184,317,997	ProgramServicesAmt
Management And General	$21,854,274	ManagementAndGeneralAmt
Fundraising	$1,462,652	FundraisingAmt

Advertising AdvertisingGrp

Field	Value	IRS element (for citing)
Total	$15,468,791	TotalAmt
Program Services	$12,881,187	ProgramServicesAmt
Management And General	$1,110,550	ManagementAndGeneralAmt
Fundraising	$1,477,054	FundraisingAmt

Office Expenses OfficeExpensesGrp

Field	Value	IRS element (for citing)
Total	$30,468,988	TotalAmt
Program Services	$25,407,673	ProgramServicesAmt
Management And General	$4,040,102	ManagementAndGeneralAmt
Fundraising	$1,021,213	FundraisingAmt

Information Technology InformationTechnologyGrp

Field	Value	IRS element (for citing)
Total	$64,876,721	TotalAmt
Program Services	$62,877,007	ProgramServicesAmt
Management And General	$1,951,633	ManagementAndGeneralAmt
Fundraising	$48,081	FundraisingAmt

Royalties RoyaltiesGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Occupancy OccupancyGrp

Field	Value	IRS element (for citing)
Total	$134,755,738	TotalAmt
Program Services	$108,771,421	ProgramServicesAmt
Management And General	$25,981,449	ManagementAndGeneralAmt
Fundraising	$2,868	FundraisingAmt

Travel TravelGrp

Field	Value	IRS element (for citing)
Total	$6,032,793	TotalAmt
Program Services	$5,825,222	ProgramServicesAmt
Management And General	$185,168	ManagementAndGeneralAmt
Fundraising	$22,403	FundraisingAmt

Pymt Travel Entrtnmnt Pub Ofcl PymtTravelEntrtnmntPubOfclGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Conferences Meetings ConferencesMeetingsGrp

Field	Value	IRS element (for citing)
Total	$2,926,095	TotalAmt
Program Services	$705,462	ProgramServicesAmt
Management And General	$1,676,217	ManagementAndGeneralAmt
Fundraising	$544,416	FundraisingAmt

Interest InterestGrp

Field	Value	IRS element (for citing)
Total	$21,410,142	TotalAmt
Program Services	$21,105,656	ProgramServicesAmt
Management And General	$304,486	ManagementAndGeneralAmt

Payments To Affiliates PaymentsToAffiliatesGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Depreciation Depletion DepreciationDepletionGrp

Field	Value	IRS element (for citing)
Total	$97,911,944	TotalAmt
Program Services	$88,003,883	ProgramServicesAmt
Management And General	$9,908,061	ManagementAndGeneralAmt

Insurance InsuranceGrp

Field	Value	IRS element (for citing)
Total	$5,349,207	TotalAmt
Program Services	$24,051	ProgramServicesAmt
Management And General	$5,325,156	ManagementAndGeneralAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDesc	TotalTotalAmt	Program ServicesProgramServicesAmt	Management And GeneralManagementAndGeneralAmt	FundraisingFundraisingAmt
PHARMACEUTICALS	$724,785,630	$724,785,630
MISCELLANEOUS	$40,633,407	$22,640,542	$17,871,544	$121,321
MEDICAL SUPPLIES	$91,215,945	$90,513,902	$702,043
OTHER PATIENT CARE EXPENSE	$31,043,936	$31,043,936

Total Functional Expenses TotalFunctionalExpensesGrp

Field	Value	IRS element (for citing)
Total	$2,225,842,004	TotalAmt
Program Services	$1,989,558,588	ProgramServicesAmt
Management And General	$195,656,779	ManagementAndGeneralAmt
Fundraising	$40,626,637	FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

Field	Value	IRS element (for citing)
BOY	$132,413,899	BOYAmt
EOY	$152,104,020	EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

Field	Value	IRS element (for citing)
BOY	$116,972,121	BOYAmt
EOY	$76,057,876	EOYAmt

Accounts Receivable AccountsReceivableGrp

Field	Value	IRS element (for citing)
BOY	$163,645,048	BOYAmt
EOY	$213,493,799	EOYAmt

Receivables From Officers Etc ReceivablesFromOfficersEtcGrp

Field	Value	IRS element (for citing)
BOY	$1,147,770	BOYAmt
EOY	$860,126	EOYAmt

Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Inventories For Sale Or Use InventoriesForSaleOrUseGrp

Field	Value	IRS element (for citing)
BOY	$57,707,055	BOYAmt
EOY	$66,954,755	EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

Field	Value	IRS element (for citing)
BOY	$54,445,075	BOYAmt
EOY	$64,357,187	EOYAmt

Field	Value	IRS element (for citing)
Land Bldg Equip Cost Or Other Bss	$2,101,809,014	LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec	$1,098,133,350	LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

Field	Value	IRS element (for citing)
BOY	$1,046,046,153	BOYAmt
EOY	$1,003,675,664	EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Investments Other Securities InvestmentsOtherSecuritiesGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Investments Program Related InvestmentsProgramRelatedGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Intangible Assets IntangibleAssetsGrp

Field	Value	IRS element (for citing)
BOY	$7,894,580	BOYAmt
EOY	$7,894,580	EOYAmt

Other Assets Total OtherAssetsTotalGrp

Field	Value	IRS element (for citing)
BOY	$2,325,578,253	BOYAmt
EOY	$2,964,579,048	EOYAmt

Total Assets TotalAssetsGrp

Field	Value	IRS element (for citing)
BOY	$3,905,849,954	BOYAmt
EOY	$4,549,977,055	EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

Field	Value	IRS element (for citing)
BOY	$328,417,243	BOYAmt
EOY	$305,173,992	EOYAmt

Grants Payable GrantsPayableGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Deferred Revenue DeferredRevenueGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp

Field	Value	IRS element (for citing)
BOY	$509,041,424	BOYAmt
EOY	$501,804,498	EOYAmt

Escrow Account Liability EscrowAccountLiabilityGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Loans From Officers Directors LoansFromOfficersDirectorsGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp

Field	Value	IRS element (for citing)
BOY	$74,622,792	BOYAmt
EOY	$72,978,317	EOYAmt

Unsecured Notes Loans Payable UnsecuredNotesLoansPayableGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Other Liabilities OtherLiabilitiesGrp

Field	Value	IRS element (for citing)
BOY	$838,517,279	BOYAmt
EOY	$725,950,578	EOYAmt

Total Liabilities TotalLiabilitiesGrp

Field	Value	IRS element (for citing)
BOY	$1,750,598,738	BOYAmt
EOY	$1,605,907,385	EOYAmt

Field	Value	IRS element (for citing)
Organization Follows FASB117	Yes (X)	OrganizationFollowsFASB117Ind

No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp

Field	Value	IRS element (for citing)
BOY	$1,020,655,661	BOYAmt
EOY	$1,354,436,047	EOYAmt

Donor Restriction Net Assets DonorRestrictionNetAssetsGrp

Field	Value	IRS element (for citing)
BOY	$1,134,595,555	BOYAmt
EOY	$1,589,633,623	EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

Field	Value	IRS element (for citing)
BOY	$2,155,251,216	BOYAmt
EOY	$2,944,069,670	EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

Field	Value	IRS element (for citing)
BOY	$3,905,849,954	BOYAmt
EOY	$4,549,977,055	EOYAmt

Field	Value	IRS element (for citing)
Info In Schedule O Part XI	Yes (X)	InfoInScheduleOPartXIInd
Reconcilation Revenue Expnss	$191,953,326	ReconcilationRevenueExpnssAmt
Other Changes In Net Assets	$596,865,128	OtherChangesInNetAssetsAmt
Method Of Accounting Accrual	Yes (X)	MethodOfAccountingAccrualInd
Accountant Compile Or Review	false	AccountantCompileOrReviewInd
FS Audited	Yes (true)	FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

Field	Value	IRS element (for citing)
Consolidated Basis Fincl Stmt	Yes (X)	ConsolidatedBasisFinclStmtInd

Field	Value	IRS element (for citing)
Audit Committee	Yes (true)	AuditCommitteeInd
Federal Grant Audit Required	Yes (true)	FederalGrantAuditRequiredInd
Federal Grant Audit Performed	Yes (true)	FederalGrantAuditPerformedInd

Schedule A IRS990ScheduleA

Field	Value	IRS element (for citing)
Public Organization170	Yes (X)	PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$511,844,582	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$561,378,936	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$604,363,420	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$629,412,126	CurrentTaxYearMinus1YearAmt
Current Tax Year	$726,297,460	CurrentTaxYearAmt
Total	$3,033,296,524	TotalAmt

Tax Rev Levied Orgnztnl Bnft170 TaxRevLeviedOrgnztnlBnft170Grp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Govt Furn Srvc Fclts Vl170 GovtFurnSrvcFcltsVl170Grp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$511,844,582	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$561,378,936	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$604,363,420	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$629,412,126	CurrentTaxYearMinus1YearAmt
Current Tax Year	$726,297,460	CurrentTaxYearAmt
Total	$3,033,296,524	TotalAmt

Field	Value	IRS element (for citing)
Substantial Contributors Tot	$0	SubstantialContributorsTotAmt
Public Support Total170	$3,033,296,524	PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$9,251,603	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$9,629,978	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$101,304,972	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$52,614,894	CurrentTaxYearMinus1YearAmt
Current Tax Year	$113,415,703	CurrentTaxYearAmt
Total	$286,217,150	TotalAmt

Unrelated Business Net Incm170 UnrelatedBusinessNetIncm170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus2 Years	$88,157	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$126,581	CurrentTaxYearMinus1YearAmt
Current Tax Year	$93,395	CurrentTaxYearAmt
Total	$308,133	TotalAmt

Other Income170 OtherIncome170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$17,212,855	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$23,432,437	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$14,052,058	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$14,915,439	CurrentTaxYearMinus1YearAmt
Current Tax Year	$7,706,225	CurrentTaxYearAmt
Total	$77,319,014	TotalAmt

Field	Value	IRS element (for citing)
Total Support	$3,397,140,821	TotalSupportAmt
Gross Receipts Rltd Activities	$6,332,816,228	GrossReceiptsRltdActivitiesAmt
Public Support CY170	0.89290	PublicSupportCY170Pct
Public Support PY170	0.91046	PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170	Yes (X)	ThirtyThrPctSuprtTestsCY170Ind

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

Field	Value	IRS element (for citing)
Contributor	RESTRICTED	ContributorNum

Contributor Business Name ContributorBusinessName

Field	Value	IRS element (for citing)
Business Name Line1	RESTRICTED	BusinessNameLine1

Contributor US Address ContributorUSAddress

Field	Value	IRS element (for citing)
Address Line1	RESTRICTED	AddressLine1
Address Line2	RESTRICTED	AddressLine2
City	RESTRICTED	City
State	RESTRICTED	State
ZIP Code	RESTRICTED	ZIPCode

Field	Value	IRS element (for citing)
Total Contributions	RESTRICTED	TotalContributionsAmt

Schedule C IRS990ScheduleC

Field	Value	IRS element (for citing)
Total Grassroots Lobbying		TotalGrassrootsLobbyingGrp
Total Direct Lobbying		TotalDirectLobbyingGrp
Total Lobbying Expend		TotalLobbyingExpendGrp
Other Exempt Purpose Expend		OtherExemptPurposeExpendGrp
Total Exempt Purpose Expend		TotalExemptPurposeExpendGrp
Lobbying Nontaxable Amount		LobbyingNontaxableAmountGrp
Grassroots Nontaxable		GrassrootsNontaxableGrp
Tot Lbbyng Grassroot Mns Non Tx		TotLbbyngGrassrootMnsNonTxGrp
Tot Lbby Expend Mns Lbbyng Non Tx		TotLbbyExpendMnsLbbyngNonTxGrp
Volunteers	Yes (true)	VolunteersInd
Paid Staff Or Management	Yes (true)	PaidStaffOrManagementInd
Media Advertisements	false	MediaAdvertisementsInd
Mailings Members	Yes (true)	MailingsMembersInd
Publications Or Broadcast	false	PublicationsOrBroadcastInd
Grants Other Organizations	Yes (true)	GrantsOtherOrganizationsInd
Grants Other Organizations	$310,411	GrantsOtherOrganizationsAmt
Direct Contact Legislators	Yes (true)	DirectContactLegislatorsInd
Direct Contact Legislators	$221,424	DirectContactLegislatorsAmt
Rallies Demonstrations	false	RalliesDemonstrationsInd
Other Activities	false	OtherActivitiesInd
Total Lobbying Expenditures	$531,835	TotalLobbyingExpendituresAmt
Not Described Section501c3	false	NotDescribedSection501c3Ind

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	SCHEDULE C, PART II-B	FormAndLineReferenceDesc
Explanation	VAN SCOYOC & ASSOCIATES PROVIDED FEDERAL LEGISLATIVE CONSULTING FOR DANA-FARBER CANCER INSTITUTE, INC. (DFCI). MCDERMOTT, QUILTY & MILLER, LLP PROVIDED STATE LEGISLATIVE AND GOVERNMENT RELATIONS CONSULTING ON HEALTH INTERESTS TO DFCI. CONFERENCE OF BOSTON HOSPITALS PROVIDED STATE AND FEDERAL LOBBYING SUPPORT TO DFCI. ALLIANCE OF DEDICATED CANCER CENTERS REPRESENTS THE NATION'S TEN FREESTANDING CANCER CENTERS. WE WORK TOGETHER ON FEDERAL REGULATORY, LEGISLATIVE, AND REIMBURSEMENT ISSUES UNIQUE TO DEDICATED CANCER CENTERS. CQ ROLL CALL PROVIDES GRASSROOTS ADVOCACY SOFTWARE USED FOR EMAILS AND ACTION ALERTS ON ADVOCACY ISSUES WHICH ARE SENT TO MEMBERS OF DANA-FARBER'S LEGISLATIVE ACTION NETWORK (LAN). DFCI'S LAN ADVOCATES FOR LEGISLATION AND POLICIES THAT IMPROVE THE LIVES OF CANCER PATIENTS. DFCI IS A MEMBER OF THE AMERICAN HOSPITAL ASSOCIATION AND THE MASSACHUSETTS HOSPITAL ASSOCIATION, NOT-FOR-PROFIT ORGANIZATIONS THAT REPRESENT AND ADVOCATE FOR THE COLLECTIVE INTERESTS OF THEIR MEMBER HOSPITALS AND HEALTH SYSTEMS THROUGH LEADERSHIP IN PUBLIC ADVOCACY, EDUCATION, AND INFORMATION. A PORTION OF THE MEMBERSHIP DUES TO THESE ORGANIZATIONS ARE USED FOR LOBBYING ACTIVITIES. ON OCCASION, DFCI EXECUTIVE LEADERSHIP MEET WITH STATE AND FEDERAL ELECTED OFFICIALS TO ADVOCATE FOR THE PASSAGE OF LEGISLATION AND FUNDING TO ADVANCE CANCER RESEARCH AND TREATMENT, AND LEGISLATION TO SUPPORT SERVICES FOR CANCER PATIENTS AND CANCER SURVIVORS. IN ADDITION, DFCI SUBMITS LETTERS AND/OR TESTIMONY TO ELECTED OFFICIALS AND POLICY MAKERS ON THESE ISSUES.	ExplanationTxt

Schedule D IRS990ScheduleD

Field	Value	IRS element (for citing)
Art Public Exhibition Amounts		ArtPublicExhibitionAmountsGrp
Held Works Art		HeldWorksArtGrp

CY Endwmt Fund CYEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$357,421,000	BeginningYearBalanceAmt
Contributions	$14,528,000	ContributionsAmt
Investment Earnings Or Losses	$122,237,000	InvestmentEarningsOrLossesAmt
Other Expenditures	$14,990,000	OtherExpendituresAmt
End Year Balance	$479,196,000	EndYearBalanceAmt

CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$313,020,000	BeginningYearBalanceAmt
Contributions	$21,879,000	ContributionsAmt
Investment Earnings Or Losses	$41,043,000	InvestmentEarningsOrLossesAmt
Other Expenditures	$18,521,000	OtherExpendituresAmt
End Year Balance	$357,421,000	EndYearBalanceAmt

CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$301,578,000	BeginningYearBalanceAmt
Contributions	$11,140,000	ContributionsAmt
Investment Earnings Or Losses	$18,454,000	InvestmentEarningsOrLossesAmt
Other Expenditures	$18,152,000	OtherExpendituresAmt
End Year Balance	$313,020,000	EndYearBalanceAmt

CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$276,248,000	BeginningYearBalanceAmt
Contributions	$12,288,000	ContributionsAmt
Investment Earnings Or Losses	$30,131,000	InvestmentEarningsOrLossesAmt
Other Expenditures	$17,089,000	OtherExpendituresAmt
End Year Balance	$301,578,000	EndYearBalanceAmt

CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$252,162,000	BeginningYearBalanceAmt
Contributions	$9,815,000	ContributionsAmt
Investment Earnings Or Losses	$32,600,000	InvestmentEarningsOrLossesAmt
Other Expenditures	$18,329,000	OtherExpendituresAmt
End Year Balance	$276,248,000	EndYearBalanceAmt

Field	Value	IRS element (for citing)
Prmnnt Endowment Balance EOY	0.52710	PrmnntEndowmentBalanceEOYPct
Term Endowment Balance EOY	0.47290	TermEndowmentBalanceEOYPct
Endowments Held Unrelated Org	false	EndowmentsHeldUnrelatedOrgInd
Endowments Held Related Org	Yes (true)	EndowmentsHeldRelatedOrgInd
Related Org List Sch R	Yes (true)	RelatedOrgListSchRInd

Land LandGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$7,640,445	OtherCostOrOtherBasisAmt
Book Value	$7,640,445	BookValueAmt

Buildings BuildingsGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$1,274,227,950	OtherCostOrOtherBasisAmt
Depreciation	$613,522,748	DepreciationAmt
Book Value	$660,705,202	BookValueAmt

Leasehold Improvements LeaseholdImprovementsGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$322,573,680	OtherCostOrOtherBasisAmt
Depreciation	$120,735,998	DepreciationAmt
Book Value	$201,837,682	BookValueAmt

Equipment EquipmentGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$455,740,009	OtherCostOrOtherBasisAmt
Depreciation	$363,874,604	DepreciationAmt
Book Value	$91,865,405	BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$41,626,930	OtherCostOrOtherBasisAmt
Book Value	$41,626,930	BookValueAmt

Field	Value	IRS element (for citing)
Total Book Value Land Buildings	$1,003,675,664	TotalBookValueLandBuildingsAmt

Other Assets Org OtherAssetsOrgGrp (5 entries)

DescDesc	Book ValueBookValueAmt
INTEREST IN DANA-FARBER, INC.	$2,427,985,539
RIGHT OF USE - NET OP. LEASES	$373,686,996
RESEARCH RECEIVABLES	$72,312,481
INTEREST IN DFCCN	$45,812,000
MISCELLANEOUS ASSETS	$44,782,032

Field	Value	IRS element (for citing)
Total Book Value Other Assets	$2,964,579,048	TotalBookValueOtherAssetsAmt
Federal Income Tax Liability	$0	FederalIncomeTaxLiabilityAmt

Other Liabilities Org OtherLiabilitiesOrgGrp (6 entries)

DescDesc	AmtAmt
OPERATING LEASE LIABILITIES	$394,937,070
RESEARCH ADVANCES	$131,125,853
MISCELLANEOUS LIABILITIES	$86,757,458
SWAP VALUATION LIABILITY	$59,630,000
AMOUNTS DUE 3RD PARTY PAYOR	$50,808,197
PROV FOR MED MALPRACTICE CLAIM	$2,692,000

Field	Value	IRS element (for citing)
Total Liability	$725,950,578	TotalLiabilityAmt

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	SCHEDULE D, PART V, LINE 4	FormAndLineReferenceDesc
Explanation	USES OF ENDOWMENT FUNDS DANA-FARBER, INC. (DFI) A RELATED ORGANIZATION OF DANA-FARBER CANCER INSTITUTE, INC. (DFCI) HOLDS THE ENDOWMENTS FOR DFCI. AS DESCRIBED IN THE CONSOLIDATED AUDITED FINANCIAL STATEMENTS, DFCI'S ENDOWMENTS CONSIST SOLELY OF DONOR-RESTRICTED ENDOWMENT FUNDS ESTABLISHED FOR PURPOSES DIRECTLY RELATED TO DFCI'S EXEMPT MISSION AND PURPOSES. AS REQUIRED BY GENERALLY ACCEPTED ACCOUNTING PRINCIPLES, NEW ASSETS ASSOCIATED WITH ENDOWMENT FUNDS ARE CLASSIFIED AND REPORTED BASED ON THE EXISTENCE OR ABSENCE OF DONOR-IMPOSED RESTRICTIONS. ALL USES OF DFCI'S ENDOWMENT FUNDS ARE IN FURTHERANCE OF DFCI'S EXEMPT MISSION AND PURPOSES.	ExplanationTxt

Schedule F IRS990ScheduleF

Account Activities Outside US AccountActivitiesOutsideUSGrp (9 entries)

RegionRegionTxt	Type Of Activities ConductedTypeOfActivitiesConductedTxt	Specific Services ProvidedSpecificServicesProvidedTxt	Region Total ExpendituresRegionTotalExpendituresAmt
South Asia	Program Services	SUBCONTRACTED RESEARCH	$395,023
North America	Program Services	SUBCONTRACTED RESEARCH	$1,333,377
Sub-Saharan Africa	Program Services	SUBCONTRACTED RESEARCH	$177,976
Europe (Including Iceland and Greenland)	Program Services	SUBCONTRACTED RESEARCH	$2,472,413
East Asia and the Pacific	Program Services	SUBCONTRACTED RESEARCH	$1,272,237
Middle East and North Africa	Program Services	SUBCONTRACTED RESEARCH	$86,033
South America	Program Services	SUBCONTRACTED RESEARCH	$286,271
East Asia and the Pacific	Program Services	RESEARCH AND EDUCATION	$1,239,192
South America	Program Services	RESEARCH AND EDUCATION	$447,547

Field	Value	IRS element (for citing)
Subtotal Offices	0	SubtotalOfficesCnt
Subtotal Employees	0	SubtotalEmployeesCnt
Total Office	0	TotalOfficeCnt
Total Employee	0	TotalEmployeeCnt
Subtotal Spent	$7,710,069	SubtotalSpentAmt
Total Spent	$7,710,069	TotalSpentAmt
Transfer To Foreign Corp	false	TransferToForeignCorpInd
Interest In Foreign Trust	false	InterestInForeignTrustInd
Foreign Corp Ownership	Yes (true)	ForeignCorpOwnershipInd
Passive Foreign Investmest Co	false	PassiveForeignInvestmestCoInd
Foreign Partnership	false	ForeignPartnershipInd
Boycott Countries	Yes (true)	BoycottCountriesInd

Schedule G IRS990ScheduleG

Field	Value	IRS element (for citing)
Mail Solicitations	Yes (X)	MailSolicitationsInd
Email Solicitations	Yes (X)	EmailSolicitationsInd
Phone Solicitations	Yes (X)	PhoneSolicitationsInd
In Person Solicitations	Yes (X)	InPersonSolicitationsInd
Solicitation Of Non Govt Grants	Yes (X)	SolicitationOfNonGovtGrantsInd
Solicitation Of Govt Grants	Yes (X)	SolicitationOfGovtGrantsInd
Special Fundraising Events	Yes (X)	SpecialFundraisingEventsInd
Agrmt Prof Fundraising Acty	Yes (true)	AgrmtProfFundraisingActyInd

Fundraiser Activity Info FundraiserActivityInfoGrp (2 entries)

Address Line1USAddress/AddressLine1Txt	CityUSAddress/CityNm	State AbbreviationUSAddress/StateAbbreviationCd	ZIPUSAddress/ZIPCd	ActivityActivityTxt	Fundraiser Control Of FundsFundraiserControlOfFundsInd	Gross ReceiptsGrossReceiptsAmt	Retained By ContractorRetainedByContractorAmt	Net To OrganizationNetToOrganizationAmt
TRUESENSE MARKETING
155 COMMERCE DR	FREEDOM	PA	15042	Direct Mail	false	$16,767,616	$3,827,309	$12,940,307
Grenzebach Glier Assoc
200 SOUTH MICHIGAN AVE STE 2100	CHICAGO	IL	60604	Consulting	false	$0	$147,815	$0

Field	Value	IRS element (for citing)
Total Gross Receipts	$16,767,616	TotalGrossReceiptsAmt
Total Retained By Contractors	$3,975,124	TotalRetainedByContractorsAmt
Total Net To Organization	$12,940,307	TotalNetToOrganizationAmt
All States	All States	AllStatesCd

Fundraising Event Information FundraisingEventInformationGrp

Field	Value	IRS element (for citing)
Event1	WALK	Event1Nm
Gross Receipts Event1	$7,144,828	GrossReceiptsEvent1Amt
Charitable Contri Event1	$7,112,243	CharitableContriEvent1Amt
Gross Revenue Event1	$32,585	GrossRevenueEvent1Amt
Rent Facility Costs Event1	$630	RentFacilityCostsEvent1Amt
Food And Beverage Event1	$414	FoodAndBeverageEvent1Amt
Other Direct Expenses Event1	$872,602	OtherDirectExpensesEvent1Amt
Event2	RADIO-TELETHON	Event2Nm
Gross Receipts Event2	$3,973,402	GrossReceiptsEvent2Amt
Charitable Contri Event2	$3,973,402	CharitableContriEvent2Amt
Rent Facility Costs Event2	$22,649	RentFacilityCostsEvent2Amt
Food And Beverage Event2	$716	FoodAndBeverageEvent2Amt
Other Direct Expenses Event2	$159,739	OtherDirectExpensesEvent2Amt
Other Events Total	7	OtherEventsTotalCnt
Gross Receipts Other Events	$4,737,830	GrossReceiptsOtherEventsAmt
Charitable Contri Other Events	$4,514,047	CharitableContriOtherEventsAmt
Gross Revenue Other Events	$223,783	GrossRevenueOtherEventsAmt
Rent Fclty Costs Other Events	$1,550	RentFcltyCostsOtherEventsAmt
Food And Beverage Other Events	$1,971	FoodAndBeverageOtherEventsAmt
Oth Direct Expnss Other Events	$253,386	OthDirectExpnssOtherEventsAmt
Gross Receipts Total	$15,856,060	GrossReceiptsTotalAmt
Charitable Contributions Tot	$15,599,692	CharitableContributionsTotAmt
Gross Revenue Total Events	$256,368	GrossRevenueTotalEventsAmt
Rent Fclty Costs Total Events	$24,829	RentFcltyCostsTotalEventsAmt
Food And Beverage Total Events	$3,101	FoodAndBeverageTotalEventsAmt
Oth Direct Expnss Total Events	$1,285,727	OthDirectExpnssTotalEventsAmt
Direct Expense Summary Events	$1,313,657	DirectExpenseSummaryEventsAmt
Net Income Summary	-$1,057,289	NetIncomeSummaryAmt

Schedule H IRS990ScheduleH

Field	Value	IRS element (for citing)
Financial Assistance Policy	Yes (true)	FinancialAssistancePolicyInd
Written Policy	Yes (true)	WrittenPolicyInd
All Hospitals Policy	Yes (X)	AllHospitalsPolicyInd
FPG Reference Free Care	Yes (true)	FPGReferenceFreeCareInd
Percent150	Yes (X)	Percent150Ind
FPG Reference Discounted Care	Yes (true)	FPGReferenceDiscountedCareInd
Percent300	Yes (X)	Percent300Ind
Free Care Medically Indigent	Yes (true)	FreeCareMedicallyIndigentInd
Financial Assistance Budget	Yes (true)	FinancialAssistanceBudgetInd
Expenses Exceed Budget	Yes (true)	ExpensesExceedBudgetInd
Unable To Provide Care	false	UnableToProvideCareInd
Annual Community Bnft Report	Yes (true)	AnnualCommunityBnftReportInd
Report Publically Available	Yes (true)	ReportPublicallyAvailableInd

Financial Assistance At Cost Typ FinancialAssistanceAtCostTyp

Field	Value	IRS element (for citing)
Total Community Benefit Expns	$19,162,944	TotalCommunityBenefitExpnsAmt
Direct Offsetting Revenue	-$11,429,284	DirectOffsettingRevenueAmt
Net Community Benefit Expns	$7,733,660	NetCommunityBenefitExpnsAmt
Total Expense	0.00350	TotalExpensePct

Unreimbursed Medicaid UnreimbursedMedicaidGrp

Field	Value	IRS element (for citing)
Total Community Benefit Expns	$109,666,403	TotalCommunityBenefitExpnsAmt
Direct Offsetting Revenue	-$74,521,231	DirectOffsettingRevenueAmt
Net Community Benefit Expns	$35,145,172	NetCommunityBenefitExpnsAmt
Total Expense	0.01580	TotalExpensePct

Total Financial Assistance Typ TotalFinancialAssistanceTyp

Field	Value	IRS element (for citing)
Total Community Benefit Expns	$128,829,347	TotalCommunityBenefitExpnsAmt
Direct Offsetting Revenue	-$85,950,515	DirectOffsettingRevenueAmt
Net Community Benefit Expns	$42,878,832	NetCommunityBenefitExpnsAmt
Total Expense	0.01930	TotalExpensePct

Community Health Services CommunityHealthServicesGrp

Field	Value	IRS element (for citing)
Total Community Benefit Expns	$5,347,898	TotalCommunityBenefitExpnsAmt
Net Community Benefit Expns	$5,347,898	NetCommunityBenefitExpnsAmt
Total Expense	0.00240	TotalExpensePct

Health Professions Education HealthProfessionsEducationGrp

Field	Value	IRS element (for citing)
Total Community Benefit Expns	$5,928,888	TotalCommunityBenefitExpnsAmt
Direct Offsetting Revenue	-$847,436	DirectOffsettingRevenueAmt
Net Community Benefit Expns	$5,081,452	NetCommunityBenefitExpnsAmt
Total Expense	0.00230	TotalExpensePct

Research ResearchGrp

Field	Value	IRS element (for citing)
Total Community Benefit Expns	$698,643,902	TotalCommunityBenefitExpnsAmt
Direct Offsetting Revenue	-$563,952,257	DirectOffsettingRevenueAmt
Net Community Benefit Expns	$134,691,645	NetCommunityBenefitExpnsAmt
Total Expense	0.06050	TotalExpensePct

Cash And In Kind Contributions CashAndInKindContributionsGrp

Field	Value	IRS element (for citing)
Total Community Benefit Expns	$3,059,984	TotalCommunityBenefitExpnsAmt
Net Community Benefit Expns	$3,059,984	NetCommunityBenefitExpnsAmt
Total Expense	0.00140	TotalExpensePct

Total Other Benefits TotalOtherBenefitsGrp

Field	Value	IRS element (for citing)
Total Community Benefit Expns	$712,980,672	TotalCommunityBenefitExpnsAmt
Direct Offsetting Revenue	-$564,799,693	DirectOffsettingRevenueAmt
Net Community Benefit Expns	$148,180,979	NetCommunityBenefitExpnsAmt
Total Expense	0.06660	TotalExpensePct

Total Community Benefits TotalCommunityBenefitsGrp

Field	Value	IRS element (for citing)
Total Community Benefit Expns	$841,810,019	TotalCommunityBenefitExpnsAmt
Direct Offsetting Revenue	-$650,750,208	DirectOffsettingRevenueAmt
Net Community Benefit Expns	$191,059,811	NetCommunityBenefitExpnsAmt
Total Expense	0.08590	TotalExpensePct

Physical Imprv And Housing PhysicalImprvAndHousingGrp

Field	Value	IRS element (for citing)
Total Community Benefit Expns	$2,307,767	TotalCommunityBenefitExpnsAmt
Net Community Benefit Expns	$2,307,767	NetCommunityBenefitExpnsAmt
Total Expense	0.00120	TotalExpensePct

Workforce Development WorkforceDevelopmentGrp

Field	Value	IRS element (for citing)
Total Community Benefit Expns	$524,900	TotalCommunityBenefitExpnsAmt
Net Community Benefit Expns	$524,900	NetCommunityBenefitExpnsAmt
Total Expense	0.00030	TotalExpensePct

Total Communtity Building Acty TotalCommuntityBuildingActyGrp

Field	Value	IRS element (for citing)
Total Community Benefit Expns	$2,832,667	TotalCommunityBenefitExpnsAmt
Net Community Benefit Expns	$2,832,667	NetCommunityBenefitExpnsAmt
Total Expense	0.00150	TotalExpensePct

Field	Value	IRS element (for citing)
Bad Debt Expense Reported	Yes (true)	BadDebtExpenseReportedInd
Bad Debt Expense	$22,788	BadDebtExpenseAmt
Bad Debt Expense Attributable	$228	BadDebtExpenseAttributableAmt
Reimbursed By Medicare	$376,000,362	ReimbursedByMedicareAmt
Cost Of Care Reimbursed By Medcr	$419,448,166	CostOfCareReimbursedByMedcrAmt
Medicare Surplus Or Shortfall	-$43,447,804	MedicareSurplusOrShortfallAmt

Costing Methodology Used CostingMethodologyUsedGrp

Field	Value	IRS element (for citing)
Other	Yes (X)	OtherInd

Field	Value	IRS element (for citing)
Written Debt Collection Policy	Yes (true)	WrittenDebtCollectionPolicyInd
Financial Assistance Prvsn	Yes (true)	FinancialAssistancePrvsnInd
Hospital Facilities	1	HospitalFacilitiesCnt

Hospital Facilities HospitalFacilitiesGrp

Field	Value	IRS element (for citing)
Facility	1	FacilityNum

Business Name BusinessName

Field	Value	IRS element (for citing)
Business Name Line1	DANA-FARBER CANCER INSTITUTE INC	BusinessNameLine1Txt

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	450 BROOKLINE AVE	AddressLine1Txt
City	BOSTON	CityNm
State Abbreviation	MA	StateAbbreviationCd
ZIP	02215	ZIPCd

Field	Value	IRS element (for citing)
Website Address	www.dana-farber.org	WebsiteAddressTxt
State License	MA LICENSE NO 2335	StateLicenseNum
Licensed Hospital	Yes (X)	LicensedHospitalInd
Teaching Hospital	Yes (X)	TeachingHospitalInd
Research Facility	Yes (X)	ResearchFacilityInd
Facility Reporting Group	A	FacilityReportingGroupCd

Hospital Fclty Policies Prctc HospitalFcltyPoliciesPrctcGrp

Hospital Facility Name HospitalFacilityName

Field	Value	IRS element (for citing)
Business Name Line1	A	BusinessNameLine1Txt

Field	Value	IRS element (for citing)
Facility	1	FacilityNum
First Licensed CY Or PY	false	FirstLicensedCYOrPYInd
Tax Exempt Hospital CY Or PY	false	TaxExemptHospitalCYOrPYInd
CHNA Conducted	Yes (true)	CHNAConductedInd
Community Definition	Yes (X)	CommunityDefinitionInd
Community Demographics	Yes (X)	CommunityDemographicsInd
Existing Resources	Yes (X)	ExistingResourcesInd
How Data Obtained	Yes (X)	HowDataObtainedInd
Community Health Needs	Yes (X)	CommunityHealthNeedsInd
Other Health Issues	Yes (X)	OtherHealthIssuesInd
Community Hlth Needs Id Process	Yes (X)	CommunityHlthNeedsIdProcessInd
Consulting Process	Yes (X)	ConsultingProcessInd
Prior CHNA Impact	Yes (X)	PriorCHNAImpactInd
CHNA Conducted	18	CHNAConductedYr
Take Into Account Others Input	Yes (true)	TakeIntoAccountOthersInputInd
CHNA Conducted With Other Fclts	false	CHNAConductedWithOtherFcltsInd
CHNA Conducted With Non Fclts	false	CHNAConductedWithNonFcltsInd
CHNA Report Widely Available	Yes (true)	CHNAReportWidelyAvailableInd
Rpt Available On Own Website	Yes (X)	RptAvailableOnOwnWebsiteInd
Own Website URL	SEE PART V, SECTION C	OwnWebsiteURLTxt
Paper Copy Public Inspection	Yes (X)	PaperCopyPublicInspectionInd
Implementation Strategy Adopt	Yes (true)	ImplementationStrategyAdoptInd
Implementation Strategy Adpt	18	ImplementationStrategyAdptYr
Strategy Posted Website	Yes (true)	StrategyPostedWebsiteInd
Strategy Website URL	SEE PART V, SECTION C	StrategyWebsiteURLTxt
Organization Incur Excise Tax	false	OrganizationIncurExciseTaxInd
Elig Criteria Explained	Yes (true)	EligCriteriaExplainedInd
FPG Family Incm Lmt Free Dscnt	Yes (X)	FPGFamilyIncmLmtFreeDscntInd
FPG Family Incm Lmt Free Care	150.	FPGFamilyIncmLmtFreeCarePct
FPG Family Incm Lmt Dscnt Care	300.	FPGFamilyIncmLmtDscntCarePct
Medical Indigency Criteria	Yes (X)	MedicalIndigencyCriteriaInd
Explained Basis	Yes (true)	ExplainedBasisInd
App Financial Asst Expln	Yes (true)	AppFinancialAsstExplnInd
Described Info	Yes (X)	DescribedInfoInd
Described Suprt Doc	Yes (X)	DescribedSuprtDocInd
Provided Hospital Contact	Yes (X)	ProvidedHospitalContactInd
Includes Publicity Measures	Yes (true)	IncludesPublicityMeasuresInd
FAP Available On Website	Yes (X)	FAPAvailableOnWebsiteInd
FAP Available On Website URL	SEE PART V, SECTION C	FAPAvailableOnWebsiteURLTxt
FAP App Available On Website	Yes (X)	FAPAppAvailableOnWebsiteInd
FAP App Available On Website URL	SEE PART V, SECTION C	FAPAppAvailableOnWebsiteURLTxt
FAP Summary On Website	Yes (X)	FAPSummaryOnWebsiteInd
FAP Summary On Website URL	SEE PART V, SECTION C	FAPSummaryOnWebsiteURLTxt
FAP Avlbl On Request No Charge	Yes (X)	FAPAvlblOnRequestNoChargeInd
FAP App Avlbl On Request No Chrg	Yes (X)	FAPAppAvlblOnRequestNoChrgInd
FAP Sum Avlbl On Request No Chrg	Yes (X)	FAPSumAvlblOnRequestNoChrgInd
Notified FAP Copy Bill Display	Yes (X)	NotifiedFAPCopyBillDisplayInd
Communtity Notified FAP	Yes (X)	CommuntityNotifiedFAPInd
FAP Translated	Yes (X)	FAPTranslatedInd
FAP Actions On Nonpayment	Yes (true)	FAPActionsOnNonpaymentInd
Permit No Actions	Yes (X)	PermitNoActionsInd
Collection Activities	false	CollectionActivitiesInd
Provided Written Notice	Yes (X)	ProvidedWrittenNoticeInd
Made Effort Orally Notify	Yes (X)	MadeEffortOrallyNotifyInd
Processed FAP Application	Yes (X)	ProcessedFAPApplicationInd
Nondis Emergency Care Policy	Yes (true)	NondisEmergencyCarePolicyInd
Look Back Medicaid Medcr Prvt	Yes (X)	LookBackMedicaidMedcrPrvtInd
Amounts Generally Billed	false	AmountsGenerallyBilledInd
Gross Charges	false	GrossChargesInd

Supplemental Information SupplementalInformationGrp (4 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
Part V, SECTION B, Line 5	IN SEPTEMBER 2019, DANA-FARBER'S BOARD OF TRUSTEES APPROVED THE 2020-2023 CANCER-FOCUSED COMMUNITY HEALTH NEEDS ASSESSMENT (CHNA) AND IMPLEMENTATION PLAN TO ENSURE THAT OUR COLLECTIVE EFFORTS HAVE THE MAXIMUM POSSIBLE IMPACT WITHIN THE INSTITUTE'S PRIORITY NEIGHBORHOODS. DANA-FARBER'S COMMUNITY BENEFITS OFFICE RETAINED HEALTH RESOURCES IN ACTION (HRIA), A NON-PROFIT PUBLIC HEALTH CONSULTANCY ORGANIZATION IN BOSTON, TO UNDERTAKE A COMPREHENSIVE ASSESSMENT OF THE HEALTH NEEDS WITHIN OUR PRIORITY COMMUNITIES, INCLUDING HOW THOSE NEEDS ARE CURRENTLY BEING ADDRESSED AND WHERE THERE ARE OPPORTUNITIES TO ADDRESS THESE NEEDS IN THE FUTURE. DANA-FARBER'S 2020-2023 CANCER CHNA BUILDS OFF OF INFORMATION GATHERED FOR BOSTON'S FIRST LARGE-SCALE COLLABORATIVE CITYWIDE COMMUNITY HEALTH NEEDS ASSESSMENT IN WHICH TARGET NEIGHBORHOODS SUCH AS DORCHESTER, ROXBURY, JAMAICA PLAIN, MISSION HILL, AND MATTAPAN WERE INVESTIGATED THOROUGHLY. THE PURPOSE OF THE CHNA IS TO ADVANCE COMMUNITY EFFORTS AND PRIORITY AREAS BY: ASSESSING CANCER BURDEN IN THE COMMUNITY AS WELL AS ACCESS TO AND AVAILABILITY OF CANCER-RELATED SERVICES; IDENTIFYING KEY AREAS OF SIGNIFICANT COMMUNITY NEED AND VULNERABLE POPULATIONS; EXAMINING THE IMPACT AND ROLE OF SOCIAL DETERMINANTS OF HEALTH; AND FACILITATING THE DEVELOPMENT OF MULTI-YEAR IMPLEMENTATION STRATEGIES TO GUIDE THE HOSPITALS' COMMUNITY HEALTH INITIATIVES AND COMMUNITY INVESTMENTS. IN ADDITION TO IDENTIFYING BROAD HEALTH ISSUES FACING RESIDENTS, THE 2019 CHNA INVESTIGATES THE FULL CONTINUUM OF CANCER CARE; IT EXPLORES DIFFERENT ASPECTS OF CARE FROM INITIAL SCREENING, TO TREATMENT, AND CULMINATES WITH CONSIDERATIONS OF SURVIVORSHIP. THE BOSTON CHNA-CHIP COLLABORATIVE IS A NEW INITIATIVE THAT WAS CREATED AND LAUNCHED BY A NUMBER OF STAKEHOLDERS-COMMUNITY ORGANIZATIONS, HEALTH CENTERS, COMMUNITY DEVELOPMENT CORPORATIONS, HOSPITALS, AND THE BOSTON PUBLIC HEALTH COMMISSION. IT AIMS TO UNDERTAKE THE FIRST LARGE-SCALE COLLABORATIVE CITYWIDE COMMUNITY HEALTH NEEDS ASSESSMENT (BOSTON CHNA) AND COMMUNITY HEALTH IMPROVEMENT PLANNING (BOSTON CHIP) PROCESS. THE GOALS OF THE BOSTON CHNA ARE TO SYSTEMATICALLY IDENTIFY THE HEALTH-RELATED NEEDS, STRENGTHS, AND RESOURCES OF COMMUNITIES TO INFORM FUTURE PLANNING, UNDERSTAND THE CURRENT HEALTH STATUS OF BOSTON OVERALL AND ITS SUB-POPULATIONS WITHIN THEIR SOCIAL CONTEXT, AND MEET REGULATORY REQUIREMENTS FOR A NUMBER OF INSTITUTIONS, ORGANIZATIONS, AND AGENCIES (E.G. IRS REQUIREMENTS FOR NON-PROFIT HOSPITALS, PHAB FOR HEALTH DEPARTMENTS). DURING THE CITYWIDE CHNA, AS A MEMBER OF THE STEERING COMMITTEE AND CO-CHAIR OF THE COMMUNITY ENGAGEMENT WORK GROUP, DANA-FARBER WORKED CLOSELY WITH MEMBERS OF THE BOSTON CHNA/CHIP COLLABORATIVE TO CONDUCT A ROBUST DATA COLLECTION AND ENGAGEMENT PROCESS FOR THE BOSTON CHNA. A CITYWIDE SURVEY WAS ADMINISTERED ONLINE AND IN-PERSON IN 7 LANGUAGES (ENGLISH, SPANISH, PORTUGUESE, HAITIAN CREOLE, CHINESE, VIETNAMESE, AND ARABIC), ENGAGING OVER 90 ORGANIZATIONS AND OVER 2,400 BOSTON RESIDENTS, WITH A FOCUS ON TARGETING HARD TO REACH POPULATIONS NOT TYPICALLY REPRESENTED. A TOTAL OF 13 FOCUS GROUPS WERE CONDUCTED WITH SPECIFIC POPULATIONS, 45 INTERVIEWS WERE HELD WITH ORGANIZATIONAL AND COMMUNITY LEADERS ACROSS VARIOUS SECTORS TO GAUGE THEIR PERCEPTIONS OF COMMUNITY NEEDS, STRENGTHS, AND OPPORTUNITIES. SECTORS REPRESENTED IN THESE INTERVIEWS INCLUDED: PUBLIC HEALTH, HEALTH CARE, HOUSING AND HOMELESSNESS, TRANSPORTATION, COMMUNITY DEVELOPMENT, FAITH, EDUCATION, PUBLIC SAFETY, ENVIRONMENTAL JUSTICE, GOVERNMENT, WORKFORCE DEVELOPMENT, SOCIAL SERVICES, FOOD INSECURITY, AND BUSINESS ORGANIZATIONAL STAFF THAT WORK WITH SPECIFIC POPULATIONS SUCH AS YOUTH, SENIORS, DISABLED, LGBTQ, AND IMMIGRANTS. DURING THE CANCER CHNA, 8 FOCUS GROUPS WERE CONDUCTED WITH ADULT CANCER PATIENTS IN ACTIVE TREATMENT, SURVIVORS, AND CAREGIVERS IN ENGLISH, SPANISH, AND CHINESE. 7 CANCER-SPECIFIC KEY INFORMANT INTERVIEWS WERE HELD WITH CANCER REPRESENTATIVES FROM ROLES RELATED TO PRIMARY CARE, PATIENT NAVIGATION AND ADVOCACY. KEY INFORMANTS REPRESENTED A NUMBER OF SECTORS INCLUDING ACADEMIC RESEARCH, HEALTH CARE, PUBLIC HEALTH, SOCIAL SERVICE, AND CITY GOVERNMENT. DISCUSSIONS EXPLORED PARTICIPANTS' PERCEPTIONS OF THEIR COMMUNITIES, PRIORITY HEALTH CONCERNS, PERCEPTIONS OF CANCER AND RELATED SERVICES ACROSS THE CANCER CONTINUUM (PREVENTION, SCREENING, TREATMENT, SURVIVORSHIP), AND SUGGESTIONS FOR FUTURE SERVICES AND RESOURCES TO ADDRESS THESE ISSUES. THE STRATEGIES AND GOALS OUTLINED IN OUR 2020-2023 CHNA IMPLEMENTATION PLAN ARE A NATURAL CONTINUATION OF THE EFFORTS IDENTIFIED IN OUR 2016-2019 PLAN AND ARE DESIGNED TO ADVANCE AND STRENGTHEN OUR EXISTING COMMUNITY-BASED INITIATIVES WHILE ALSO SEEKING TO ADDRESS THE SOCIAL DETERMINANTS OF HEALTH THROUGH COLLABORATIVE PARTNERSHIPS.
PART V, SECTION B, LINE 7A	DFCI'S COMMUNITY HEALTH NEEDS ASSESSMENT REPORT IS AVAILABLE ON THE DFCI WEBSITE. https://www.dana-farber.org/uploadedFiles/Pages/About_Us/Community_Outreac h/chna-report-approved-9.11.19.pdf
PART V, SECTION B, LINE 10A	DFCI'S IMPLEMENTATION STRATEGY IS AVAILABLE ON THE DFCI WEBSITE. https://www.dana-farber.org/uploadedFiles/Pages/About_Us/Community_Outreac h/chna-chip-board-approved-12.23.2019.pdf PART V, SECTION B, LINE 11 DANA-FARBER CANCER INSTITUTE ADDRESSED ALL THE NEEDS IDENTIFIED IN THE COMMUNITY HEALTH NEEDS ASSESSMENT AND THE ACCOMPANYING IMPLEMENTATION PLAN. A FULL DESCRIPTION OF OUR PROGRAMS IS AVAILABLE ON OUR WEBSITE BOTH IN THE COMMUNITY HEALTH NEEDS ASSESSMENT REPORT AND IN THE COMMUNITY HEALTH IMPLEMENTATION PLAN. WHILE OUR EXPERTISE AS A COMPREHENSIVE CANCER CENTER LEADS US TO FOCUS LARGELY ON REDUCING CANCER INCIDENCE AND MORTALITY AMONG MEDICALLY UNDERSERVED POPULATIONS THROUGH OUR CLINICAL COMMUNITY SCREENING AND OUTREACH PROGRAMS THAT INCLUDE MOBILE MAMMOGRAPHY AND BREAST HEALTH EDUCATION, SKIN CANCER EDUCATION AND SCREENING, HPV EDUCATION AND VACCINATION, TOBACCO CESSATION AND INCREASING AWARENESS ABOUT SURVIVORSHIP IN COMMUNITIES OF COLOR, WE RECOGNIZE THAT OUR PRIORITY NEIGHBORHOODS ARE ALSO DEALING DISPROPORTIONATELY WITH CHALLENGING SITUATIONS RELATED TO SOCIAL AND ECONOMIC FACTORS SUCH AS LIMITED EMPLOYMENT OPPORTUNITIES, SUBSTANCE ABUSE AND OPIOID ADDICTION, LOW EDUCATION LEVELS, LACK OF AFFORDABLE HOUSING, AND COMMUNITY VIOLENCE, AMONG OTHERS. WE WORK ON THESE BROADER ISSUES BY ADVOCATING AND BY PARTNERING WITH LOCAL COALITIONS AND COMMUNITY BASED ORGANIZATIONS SUCH AS BOSTON ALLIANCE FOR COMMUNITY HEALTH AND MEMBER ORGANIZATIONS.
PART V, SECTION B, LINE 16A	DFCI'S FINANCIAL ASSISTANCE POLICY IS AVAILABLE ON THE DFCI WEBSITE. HTTPS://WWW.DANA-FARBER.ORG/UPLOADEDFILES/PAGES/FOR_PATIENTS_AND_FAMILIES/ CARE_AND_TREATMENT/SUPPORT_SERVICES_AND_AMENITIES/FINANCIAL-ASSISTANCE-FUL L-POLICY.PDF PART V, SECTION B, LINE 16B DFCI'S FINANCIAL ASSISTANCE POLICY APPLICATION FORM IS AVAILABLE ON THE DFCI WEBSITE. HTTPS://WWW.DANA-FARBER.ORG/UPLOADEDFILES/PAGES/FOR_PATIENTS_AND_FAMILIES/ CARE_AND_TREATMENT/SUPPORT_SERVICES_AND_AMENITIES/FINANCIAL-ASSISTANCE-APP LICATION.PDF PART V, SECTION B, LINE 16C DFCI'S FINANCIAL ASSISTANCE POLICY PLAIN LANGUAGE SUMMARY IS AVAILABLE ON THE DFCI WEBSITE. HTTPS://WWW.DANA-FARBER.ORG/UPLOADEDFILES/PAGES/FOR_PATIENTS_AND_FAMILIES/ CARE_AND_TREATMENT/SUPPORT_SERVICES_AND_AMENITIES/FINANCIAL-ASSISTANCE-SUM MARY.PDF PART V, SECTION B, LINE 22 DEPENDING ON A PATIENT'S FINANCIAL SITUATION, FAP-ELIGIBLE PATIENTS WERE CHARGED BETWEEN 0% TO 30% OF BILLED CHARGES, WHICH WAS NOT MORE THAN THE AGB. IN FY21, DFCI DETERMINED AGB ON AN ANNUAL BASIS USING THE "LOOK-BACK METHOD," DESCRIBED UNDER TREASURY REGULATION SECTION 1.501(R)-5(B)(1). SPECIFICALLY, DFCI'S ANNUAL AGB PERCENTAGE WAS EQUAL TO THE SUM OF ALL GROSS CHARGES DURING THE PRIOR FISCAL YEAR DIVIDED BY CLAIMS PAID IN CONNECTION WITH THOSE CHARGES. FOR PURPOSES OF THE AGB CALCULATION, CLAIMS PAID INCLUDED CLAIMS FOR EMERGENCY AND MEDICALLY NECESSARY CARE PAID BY BOTH MEDICARE FEE-FOR-SERVICE AND ALL PRIVATE HEALTH INSURERS AS PRIMARY PAYERS, TOGETHER WITH ANY ASSOCIATED PORTIONS OF THESE CLAIMS PAID BY MEDICARE BENEFICIARIES OR INSURED INDIVIDUALS IN THE FORM OF CO-PAYMENTS, CO-INSURANCE OR DEDUCTIBLES.

Field	Value	IRS element (for citing)
Facility	9	FacilityNum

Oth Hlth Care Fclts Not Hospital OthHlthCareFcltsNotHospitalGrp

Oth Hlth Care Fclts OthHlthCareFcltsGrp (9 entries)

Address Line1USAddress/AddressLine1Txt	CityUSAddress/CityNm	State AbbreviationUSAddress/StateAbbreviationCd	ZIPUSAddress/ZIPCd	FacilityFacilityTxt
DFBWCC AT SOUTH SHORE HOSPITAL
101 COLUMBIAN STREET	SOUTH WEYMOUTH	MA	02190	SATELLITE
DFBWCC AT MILFORD REGIONAL MED CNTR
20 PROSPECT STREET	MILFORD	MA	01757	SATELLITE
DFCI - CHESTNUT HILL
300 BOYLSTON STREET	NEWTON	MA	02459	SATELLITE
DFCI - MERRIMACK VALLEY
5 BRANCH STREET	METHUEN	MA	01844	SATELLITE
DFNH ONCOLOGY-HEMATOLOGY
ELLIOTT MED CENTER 40 BUTTRICK RD	LONDONDERRY	NH	03053	SATELLITE
DFCI AT ST ELIZABETH'S MEDICAL CNTR
CUSHING PAVILION 736 CAMBRIDGE STR	BRIGHTON	MA	02135	SATELLITE
DFCI - LIBBEY PARK
51 PERFORMANCE DRIVE	WEYMOUTH	MA	02189	SATELLITE
DFCI - MOBILE MAMMOGRAPHY SERVICE
450 BROOKLINE AVENUE	BOSTON	MA	02215	SATELLITE
DFCI - WHITTIER STREET HEALTH CENTER
1290 Tremont Street	Roxbury	MA	02120	SATELLITE

Supplemental Information Detail SupplementalInformationDetail (5 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
Part I, Line 3c	IN ADDITION TO DETERMINING ELIGIBILITY FOR DISCOUNTED CARE BASED ON FAMILY INCOME, DANA-FARBER CANCER INSTITUTE, INC. (DFCI) OFFERS ASSISTANCE TO PATIENTS WHO HAVE EXCESSIVE MEDICAL BILLS (EXCEEDING 30-40% OF FAMILY INCOME). Part I, Line 6a THE COMMUNITY BENEFIT REPORT WAS COMPLETED BY DFCI AND IS ANNUALLY PROVIDED TO THE MASSACHUSETTS ATTORNEY GENERAL'S OFFICE, WHERE IT IS THEN MADE AVAILABLE TO THE PUBLIC ON ITS WEBSITE. Part I, Line 7 DFCI'S STATE COST REPORT WAS USED TO DEVELOP THE INSTITUTE'S COST TO CHARGE RATIO THAT WAS APPLIED TO CHARITY CARE CHARGES TO DETERMINE THE COST OF FINANCIAL ASSISTANCE (LINE 7A). LINE 7B REFLECTS THE SPECIFIC LOSS INCURRED FOR THE INSTITUTE'S MEDICAID ACTIVITY. THE INSTITUTE IS A PREEMINENT PROVIDER OF HEALTH TRAINING TO HEALTH PROFESSIONALS WHO DESIRE TRAINING IN THE SKILLS NECESSARY TO TREAT CANCER PATIENTS. THE INSTITUTE TRAINS PHYSICIANS, SCIENTISTS, MEDICAL STUDENTS, AND INDIVIDUALS LOOKING TO CREATE A CAREER IN THE FIELD OF CANCER. THE AMOUNT REPORTED AS HEALTH TRAINING REPRESENT COSTS IN EXCESS OF AMOUNTS REIMBURSED BY THIRD PARTY PAYERS SUCH AS TRAINING GRANT REVENUES AND DIRECT MEDICAL EDUCATION PAYMENTS FROM THE MEDICARE PROGRAM. DEPARTMENT LEADERS SUBMIT EXPENDITURES TO COMMUNITY BENEFITS ALONG WITH A DESCRIPTION OF THE SERVICES PROVIDED TO MEDICALLY UNDERSERVED POPULATIONS. LINE 7F EXPENDITURES ARE REVIEWED BY LEADERSHIP AND IN PARTNERSHIP WITH DFCI'S OFFICE OF FINANCE, THE EXPENDITURES ARE APPROVED. THE AMOUNTS ARE CAPTURED IN THREE BUCKETS - CB EXPENDITURES (ALL PROGRAMS); LEVERAGED FUNDS (THOSE FUNDS SUPPORTED IN FULL OR PART THROUGH GRANTS/DONATIONS) AND COMMUNITY SPONSORSHIPS.
Part II, Line 1	PHYSICAL IMPROVEMENTS AND HOUSING - DFCI PROVIDES A LIMITED NUMBER OF LOW-COST ROOMS THAT SERVE AS A HOME AWAY FROM HOME FOR ONCOLOGY PATIENTS AND THEIR FAMILIES WHILE THEY ARE RECEIVING TREATMENT. Part II, Line 8 WORKFORCE DEVELOPMENT - TO ENCOURAGE UNDERREPRESENTED STUDENTS OF COLOR TO EXPLORE AND PURSUE CAREERS IN HEALTH AND SCIENCE, DANA-FARBER MAINTAINS EDUCATIONAL PARTNERSHIPS WITH BOSTON AREA HIGH SCHOOLS AND COLLEGES. DURING ACADEMIC YEAR 2021, 21 STUDENTS PARTICIPATED IN A COLLEGE AND CAREER READINESS TRAINING PROGRAM. AN ADDITIONAL 54 STUDENTS WERE ENROLLED DURING THE 2021 SUMMER JOBS PROGRAM AT DANA-FARBER. ELIGIBLE STUDENTS EITHER ATTENDED OR GRADUATED FROM BOSTON PUBLIC SCHOOLS. DURING THE SUMMER PROGRAM, STUDENTS INTERNED THROUGH A HYBRID PROGRAM, SOME INTERNS SERVED DEPARTMENTS REMOTELY AND OTHERS WERE ON-SITE AT DANA-FARBER. ALL PARTICIPATED IN COLLEGE TOURS AND CAREER READINESS WORKSHOPS THAT WERE HELD VIRTUALLY. PART III, SECTION A, LINES 2 & 3 IN CALCULATING BAD DEBT EXPENSE, DFCI USES A COMBINATION OF ACTUAL BAD DEBT WRITE OFFS AND HISTORICAL BAD DEBT FACTORS IN DETERMINING WHICH CURRENT ACCOUNTS RECEIVABLE ARE NOT LIKELY TO BE COLLECTED. IN FY21, DFCI RELEASED THE ADDITIONAL RESERVE FOR SOME INTERNATIONAL ACCOUNTS THAT WERE DEEMED NOT LIKELY TO BE COLLECTED. ADDITIONALLY, DFCI DETERMINES THE AMOUNT OF BAD DEBT ATTRIBUTABLE TO INDIVIDUALS WHO ARE ELIGIBLE FOR FINANCIAL ASSISTANCE BASED ON A HISTORICAL ESTIMATE OF THE PERCENTAGE OF PATIENTS THAT HAVE QUALIFIED FOR FINANCIAL ASSISTANCE, WHICH IS APPLIED AGAINST TOTAL BAD DEBT. PART III, SECTION A, LINE 4 CONSISTENT WITH THE INSTITUTE'S MISSION, CARE IS PROVIDED TO PATIENTS REGARDLESS OF THEIR ABILITY TO PAY. THE INSTITUTE HAS DETERMINED IT HAS PROVIDED IMPLICIT PRICE CONCESSIONS TO UNINSURED PATIENTS AND PATIENTS WITH OTHER UNINSURED BALANCES (E.G. COPAYS AND DEDUCTIBLES). THE IMPLICIT PRICE CONCESSIONS INCLUDED IN ESTIMATING THE TRANSACTION PRICE REPRESENT THE DIFFERENCE BETWEEN AMOUNTS BILLED TO PATIENTS AND THE AMOUNTS THE INSTITUTE EXPECTS TO COLLECT BASED ON ITS COLLECTION HISTORY WITH THOSE PATIENTS. PATIENTS WHO MEET THE INSTITUTE'S CRITERIA FOR CHARITY CARE ARE PROVIDED CARE WITHOUT CHARGE OR AT AMOUNTS LESS THAN ESTABLISHED RATES. THE INSTIUTE HAS DETERMINED THAT IT HAS PROVIDED SUFFICIENT IMPLICIT PRICE CONCESSIONS FOR THESE ACCOUNTS. PRICE CONCESSIONS, INCLUDING CHARITY CARE, ARE NOT REPORTED AS REVENUE.
PART III, SECTION B, LINE 8	THE MEDICARE COST ON LINE 6 COMES FROM THE MEDICARE COST REPORT AND IS BASED ON MEDICARE'S COST FINDING PRINCIPLES AND METHODOLOGIES. WE STRONGLY BELIEVE THAT THE ENTIRE AMOUNT OF THE SHORTFALL OF $43,447,804 SHOULD BE TREATED AS A COMMUNITY BENEFIT AS THIS REPRESENTS THE INSTITUTE'S COMMITMENT TO THE ELDERLY AND DISABLED COMMUNITY BY PROVIDING SERVICES THAT ARE NOT REIMBURSED. PART III, SECTION C, LINE 9B WITHIN DFCI'S CREDIT AND COLLECTIONS POLICY THERE ARE PROVISIONS THAT DESCRIBE COLLECTION PRACTICES TO BE FOLLOWED FOR PATIENTS WHO ARE KNOWN TO QUALIFY FOR CHARITY CARE OR FINANCIAL ASSISTANCE IN ACCORDANCE WITH FEDERAL AND MASSACHUSETTS LAW.
Part V, Sections A & D	DFCI'S MAIN CAMPUS IS AT 450 BROOKLINE AVE., BOSTON, MA, 02115. DFCI'S SATELLITE LOCATIONS (BELOW) EACH OPERATE UNDER THE SAME HOSPITAL LICENSE. DANA-FARBER/BRIGHAM AND WOMEN'S CANCER CENTER AT MILFORD HOSPITAL, 20 PROSPECT STREET, MILFORD, MA 01757, DANA-FARBER/BRIGHAM AND WOMEN'S CANCER CENTER AT SOUTH SHORE HOSPITAL, 101 COLUMBIAN STREET, SOUTH WEYMOUTH, MA 02190, DANA-FARBER AT ST. ELIZABETH'S MEDICAL CENTER, 736 CAMBRIDGE STREET, CUSHING PAVILION, 5TH FLOOR, BRIGHTON, MA 02135, DANA-FARBER CANCER INSTITUTE CHESTNUT HILL, 300 BOYLSTON STREET, NEWTON, MA 02459, DANA-FARBER CANCER INSTITUTE - MERRIMACK VALLEY, 5 BRANCH STREET, METHUEN, MA 01844, DANA-FARBER CANCER INSTITUTE - LIBBEY PARK, 51 PERFORMANCE DRIVE, WEYMOUTH, MA 02189, DANA-FARBER CANCER INSTITUTE - MOBILE MAMMOGRAPHY SERVICE, 450 BROOKLINE AVENUE, BOSTON, MA 02215, DANA-FARBER CANCER INSTITUTE - WHITTIER STREET HEALTH CENTER, 1290 TREMONT STREET, ROXBURY, MA 02120. Dana-Farber/New Hampshire Oncology Hematology also operates a clinical location at 40 Buttrick Road, Suite B, Londonderry, NH.
Part VI, Line 2	DANA-FARBER CANCER INSTITUTE CONTINUOUSLY ASSESSES THE COMMUNITY NEEDS THROUGH OUR PARTICIPATION IN COMMUNITY COALITIONS, TASK FORCES, WORKING GROUPS, AND DIRECT COMMUNICATION WITH THE COMMUNITY RESIDENTS THAT SERVE ON OUR EXTERNAL ADVISORY COMMITTEE AND ON OUR PATIENT AND FAMILY ADVISORY BOARD. A FULL DESCRIPTION OF OUR COMMUNITY ENGAGEMENT PROCESS CAN BE FOUND ON OUR WEBSITE BOTH IN THE COMMUNITY HEALTH NEEDS ASSESSMENT REPORT AND IN THE COMMUNITY HEALTH IMPLEMENTATION PLAN. Part VI, Line 3 DFCI IS COMMITTED TO OFFERING FINANCIAL ASSISTANCE TO ELIGIBLE PATIENTS WHO DO NOT HAVE THE ABILITY TO PAY FOR THEIR MEDICAL SERVICES IN WHOLE OR IN PART. IN ORDER TO ACCOMPLISH THIS CHARITABLE GOAL, DFCI WIDELY PUBLICIZES ITS PATIENT FINANCIAL ASSISTANCE (PFA) POLICY WITHIN ITS FACILITIES, IN DIRECT COMMUNICATIONS WITH PATIENTS AND IN THE COMMUNITIES THAT IT SERVICES, PARTICULARLY IN THE COMMUNITIES WITH THE GREATEST UNMET HEALTH NEEDS. THE PFA POLICY, A PLAIN LANGUAGE PFA SUMMARY, AND THE PFA APPLICATION ARE POSTED ON DFCI'S WEBSITE IN ENGLISH AND SPANISH. IN ADDITION, INFORMATION ABOUT THE PFA IS PROVIDED TO ALL PATIENTS AT REGISTRATION AND/OR ADMISSION, AND IS AVAILABLE UPON REQUEST, WITHOUT CHARGE, THROUGH A DFCI FINANCIAL COUNSELOR, CUSTOMER SERVICE REPRESENTATIVE, OR BY MAIL. FOLLOWING CARE, ALL BILLING STATEMENTS SENT TO A PATIENT INDICATE HOW THE PATIENT CAN OBTAIN INFORMATION ABOUT THE PFA POLICY. IN COLLABORATION WITH DFCI'S COMMUNITY PARTNERS, INFORMATION ABOUT THE FAP IS SHARED WITH RESIDENTS OF DFCI'S PRIORITY NEIGHBORHOODS. EFFORTS TO NOTIFY COMMUNITY MEMBERS MOST LIKELY TO REQUIRE ASSISTANCE INCLUDE DISTRIBUTING PLAIN LANGUAGE SUMMARIES OF THIS POLICY TO LOCAL COMMUNITY HEALTH CENTERS AND OTHER NON-PROFIT ORGANIZATIONS. Part VI, Line 4 DFCI SERVES THE COMMUNITY OF EASTERN MASSACHUSETTS AND NEW ENGLAND, INCLUDING THE COMMUNITIES SURROUNDING ITS PRIMARY LOCATION IN BOSTON AND ITS SATELLITE LOCATIONS IN MILFORD, WEYMOUTH, BRIGHTON, NEWTON, METHUEN, AND LONDONDERRY (NH). DFCI'S COMMUNITY INCLUDES ADULTS AND CHILDREN WITH CANCER OR AT RISK OF DEVELOPING CANCER, AND THEIR FAMILIES. DFCI FOCUSES ITS COMMUNITY OUTREACH EFFORTS ON ITS PRIORITY BOSTON NEIGHBORHOODS OF ROXBURY, MISSION HILL, DORCHESTER, MATTAPAN, AND JAMAICA PLAIN (WHICH COLLECTIVELY COMPRISE 39% OF BOSTON'S OVERALL POPULATION). TWO OF BOSTON'S MOST POPULATED NEIGHBORHOODS ARE DFCI'S PRIORITY NEIGHBORHOODS - DORCHESTER WITH 122,598 RESIDENTS, FOLLOWED BY ROXBURY WITH 49,028. WHITE RESIDENTS NOW MAKE UP LESS THAN HALF OF THE CITY'S RACIAL AND ETHNIC COMPOSITION (46%). BLACK OR AFRICAN AMERICAN RESIDENTS WERE THE SECOND LARGEST RACIAL AND ETHNIC GROUP (23%), FOLLOWED BY HISPANICS (18%), AND ASIANS (9%). THERE IS SUBSTANTIAL VARIATION IN THE RACIAL AND ETHNIC DIVERSITY BY DFCI PRIORITY NEIGHBORHOOD, WITH NEARLY THREE-QUARTERS OF MATTAPAN RESIDENTS AND HALF OF ROXBURY RESIDENTS IDENTIFYING AS BLACK OR AFRICAN AMERICAN. AMONG DFCI PRIORITY NEIGHBORHOODS, ROXBURY AND JAMAICA PLAIN HAVE THE LARGEST HISPANIC POPULATIONS WITH 29% AND 24% RESPECTIVELY, WHILE MISSION HILL AND DORCHESTER HAVE THE LARGEST ASIAN POPULATIONS AMONG THE PRIORITY NEIGHBORHOODS WITH 14% AND 10% RESPECTIVELY. THE MEDIAN INCOMES OF DFCI'S PRIORITY COMMUNITIES ARE GENERALLY MUCH LOWER THAN BOSTON OVERALL, WITH ROXBURY AT A MEDIAN INCOME OF $25,254, MISSION HILL AT $35,020, AND MATTAPAN AT $42,206. MANY OF DFCI'S PRIORITY NEIGHBORHOODS, ROXBURY AND MATTAPAN, ARE MORE LIKELY TO HAVE A GREATER POPULATION AT THE LOWER END OF THE INCOME SPECTRUM. RESIDENTS IN DFCI'S PRIORITY NEIGHBORHOODS APPEAR TO EXPERIENCE HIGHER RATES OF POVERTY THAN BOSTON OVERALL. FEMALE HEADED HOUSEHOLDS ARE ESPECIALLY VULNERABLE, WITH 45% OF ROXBURY FEMALE-HEADED HOUSEHOLDS LIVING BELOW THE POVERTY LINE. DESPITE ITS STATEWIDE REACH AND SERVICES PROVIDED THROUGH OUR SATELLITE OPERATIONS IN WEYMOUTH, MILFORD, NEWTON, METHUEN, AND ALLSTON/BRIGHTON, DANA-FARBER'S PRIORITIZATION OF THESE FIVE NEIGHBORHOODS WITHIN ITS LOCAL SERVICE AREA REFLECTS A COMMITMENT TO REDUCING DISPARITIES IN CANCER CARE AND IMPROVING THE HEALTH AND WELL-BEING OF NEIGHBORHOOD RESIDENTS. THROUGH OUR COLLABORATIVE APPROACH, THE SATELLITE LOCATIONS HAVE AGREED TO LEVERAGE EACH OTHER'S CANCER CONTROL EXPERTISE TO EXPAND AND STRENGTHEN OUR PROGRAMS SUCH AS BRINGING CANCER PREVENTION EFFORTS IN SPANISH TO THE WEYMOUTH AREA. THE ALLSTON/BRIGHTON SATELLITES HAVE ALSO MUTUALLY AGREED TO CONTINUE TO WORK TOGETHER TO STRENGTHEN MAMMOGRAPHY SCREENING RATES THROUGH OUR PARTNERSHIP WITH THE LOCAL COMMUNITY HEALTH CENTER AND TO EXPLORE OTHER OPPORTUNITIES TO HAVE GREATER IMPACT ON THE HEALTH AND WELL-BEING OF LOCAL RESIDENTS. DANA-FARBER ALSO AIMS TO PRIORITIZE POPULATIONS DISPROPORTIONATELY IMPACTED BY CANCER, INCLUDING DIVERSE RACIAL AND ETHNIC POPULATIONS, INDIVIDUALS FROM LOW SOCIOECONOMIC BACKGROUNDS, AND IMMIGRANTS. BASED ON THE CHNA DATA, THE POPULATIONS ABOVE APPEAR TO HAVE DISPROPORTIONATELY HIGHER LEVELS OF DISEASE RISK AND BURDEN, WARRANTING INCREASED ATTENTION. Part VI, Line 5 DANA-FARBER'S 2020-2023 COMMUNITY HEALTH NEEDS ASSESSMENT AND IMPLEMENTATION PLAN PROVIDE A ROBUST DESCRIPTION OF OUR COMPREHENSIVE CANCER CONTROL PROGRAMS AND SERVICES. THE REPORT ALSO PROVIDES A SUMMARY OF ACCOMPLISHMENTS FROM OUR LAST NEEDS ASSESSMENT AND SETS FORTH OUR COMMITMENT TO ADDRESSING THE NEW OPPORTUNITIES TO REDUCE THE CANCER BURDEN IN MEDICALLY UNDERSERVED COMMUNITIES IN BOSTON. THE REPORTS CAN BE FOUND USING THE FOLLOWING LINKS: COMMUNITY HEALTH NEEDS ASSESSMENT - https://www.dana-farber.org/uploadedFiles/Pages/About_Us/Community_Outreac h/chna-report-approved-9.11.19.pdf IMPLEMENTATION PLAN - https://www.dana-farber.org/uploadedFiles/Pages/About_Us/Community_Outreac h/chna-chip-board-approved-12.23.2019.pdf IN ADDITION, DFCI FURTHERS ITS EXEMPT PURPOSE BY PROMOTING THE HEALTH OF THE COMMUNITY THROUGH DEVOTING THE VAST MAJORITY OF ITS SURPLUS FUNDS TO INSTITUTIONAL SUPPORTED RESEARCH (135 MILLION), BY PROVIDING FINANCIAL ASSISTANCE TO PATIENTS UNABLE TO AFFORD CARE AND BY MAINTAINING A COMMUNITY BOARD. PART VI, LINE 7 DFCI FILES ITS COMMUNITY BENEFIT REPORT WITH THE STATE OF MASSACHUSETTS.

Schedule I IRS990ScheduleI

Field	Value	IRS element (for citing)
Grant Records Maintained	Yes (true)	GrantRecordsMaintainedInd

Recipient Table RecipientTable (14 entries)

Address Line1USAddress/AddressLine1Txt	CityUSAddress/CityNm	State AbbreviationUSAddress/StateAbbreviationCd	ZIPUSAddress/ZIPCd	Recipient EINRecipientEIN	IRC SectionIRCSectionDesc	Cash GrantCashGrantAmt	Purpose Of GrantPurposeOfGrantTxt
AMERICAN CANCER SOCIETY
250 Williams St	Atlanta	GA	30303	131788491	501(c)(3)	$20,000	CANCER RES AND DEVLP
BOSTON PRIVATE INDUSTRY COUNCIL
2 Oliver St	Boston	MA	02109	042676661	501(c)(3)	$10,000	CANCER RES AND DEVLP
BOSTON PUBLIC HEALTH COMMISSION
1010 Massachusetts Ave	BOSTON	MA	02118	043316655	115	$10,000	COMMUNITY SUPPORT
City of Boston
City Hall Plaza	Boston	MA	02114	046001380	115	$1,533,623	COMMUNITY SUPPORT
Friends of Dana-Farber
450 Brookline Ave	Boston	MA	02215	371613621	501(c)(3)	$50,000	CANCER RES AND DEVLP
HARVARD UNIVERSITY
60 Oxford Street	CAMBRIDGE	MA	02138	042103580	501(c)(3)	$1,333,475	CANCER RES AND DEVLP
INTERNATIONAL SOCIETY OF STEM CELL
5215 Old Orchard Rd NO 270	SKOKIE	IL	60077	364491158	501(c)(3)	$10,000	CANCER RES AND DEVLP
LEUKEMIA & LYMPHOMA SOCIETY INC
1311 MAMARONECK AVE	WHITE PLANES	NY	10605	135644916	501(c)(3)	$40,000	CANCER RES AND DEVLP
Madison Park Development Corporation
184 Dudley St	Roxbury	MA	02119	237164223	501(c)(3)	$21,250	COMMUNITY SUPPORT
PROSTATE HEALTH EDUCATION NETWORK INC
500 Victory Rd 4th FL	Quincy	MA	02453	331042404	501(c)(3)	$30,000	CANCER RES AND DEVLP
RESEARCH AMERICA
241 18th St So NO 501	Arlington	VA	22202	521609875	501(c)(3)	$8,600	CANCER RES AND DEVLP
SWIM ACROSS AMERICA INC
8508 Park Road NO 389	charlotte	NC	28210	223248256	501(c)(3)	$15,000	CANCER RES AND DEVLP
UNITED WAY OF MASSACHUSETTS BAY
51 Sleeper St	Boston	MA	02210	042382233	501(c)(3)	$10,000	Community Support
Whittier Street Health Center
1125 TREMONT STREET	ROXBURY	MA	02120	042619517	501(c)(3)	$144,270	COMMUNITY SUPPORT

Field	Value	IRS element (for citing)
Total501c3 Org	12	Total501c3OrgCnt
Total Other Org	2	TotalOtherOrgCnt

Grants Other Asst To Indiv In US GrantsOtherAsstToIndivInUSGrp (2 entries)

Grant TypeGrantTypeTxt	RecipientRecipientCnt	Cash GrantCashGrantAmt	Non Cash AssistanceNonCashAssistanceAmt	Valuation Method UsedValuationMethodUsedDesc	Non Cash AssistanceNonCashAssistanceDesc
Patient Assistance	645	$619,159
Patient Assistance	2788		$1,422,185	FMV	ASST LIVING & TRAVEL

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	Schedule I, Part I, Line 2	FormAndLineReferenceDesc
Explanation	PROCEDURES FOR MONITORING THE USE OF GRANT FUNDS ALL GRANTS AND DONATIONS TO DOMESTIC ORGANIZATIONS WERE GIVEN TO 501(C)(3) ORGANIZATIONS TO FULFILL THEIR MISSIONS, OR GOVERNMENT ENTITIES. ALL GRANT FUNDS TO INDIVIDUALS WERE PROVIDED BASED ON EITHER (AND ONLY) 1) MEANS-TESTED FINANCIAL NEED, OR 2) CLINICALLY-DETERMINED IMPROVEMENT TO QUALITY-OF-LIFE.	ExplanationTxt

Schedule J IRS990ScheduleJ

Field	Value	IRS element (for citing)
Compensation Committee	Yes (X)	CompensationCommitteeInd
Independent Consultant	Yes (X)	IndependentConsultantInd
Form990 Of Other Organizations	Yes (X)	Form990OfOtherOrganizationsInd
Compensation Survey	Yes (X)	CompensationSurveyInd
Board Or Committee Approval	Yes (X)	BoardOrCommitteeApprovalInd
Severance Payment	Yes (true)	SeverancePaymentInd
Supplemental Nonqual Rtr Plan	Yes (true)	SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm	false	EquityBasedCompArrngmInd
Comp Based On Revenue Of Flng Org	false	CompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related Orgs	false	CompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng Org	false	CompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd Orgs	false	CompBsdNetEarnsRltdOrgsInd
Any Non Fixed Payments	Yes (true)	AnyNonFixedPaymentsInd
Initial Contract Exception	false	InitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (23 entries)

TitleTitleTxt	Base Compensation Filing OrgBaseCompensationFilingOrgAmt	Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt	Bonus Filing OrganizationBonusFilingOrganizationAmount	Bonus Related OrganizationsBonusRelatedOrganizationsAmt	Other Compensation Filing OrgOtherCompensationFilingOrgAmt	Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt	Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt	Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt	Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt	Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt	Total Compensation Filing OrgTotalCompensationFilingOrgAmt	Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt	Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt	Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
Glimcher Laurie H MD
Trustee, President and CEO	$1,220,120	$0	$422,902	$0	$81,203	$0	$285,781	$0	$16,612	$0	$2,026,618	$0	$0	$0
Benz Edward J JR MD
President and CEO Emeritus	$565,636	$0	$400	$0	$567,346	$0	$40,140	$0	$17,287	$0	$1,190,809	$0	$0	$0
Reney Michael L
CFO and Asst. Treasurer	$685,477	$0	$117,535	$0	$26,029	$0	$40,140	$0	$3,754	$0	$872,935	$0	$0	$0
Hahn William MD PHD
COO & EVP	$575,714	$0	$210,752	$0	$12,566	$0	$40,140	$0	$3,320	$0	$842,492	$0	$0	$0
Terwilliger James
FORMER COO & EVP	$354,604	$0	$82,716	$0	$377,877	$0	$0	$0	$24,858	$0	$840,055	$0	$0	$0
Bunnell Craig A MD
CHIEF MEDICAL OFFICER	$637,037	$0	$115,977	$0	$23,201	$0	$40,140	$0	$6,303	$0	$822,658	$0	$0	$0
Winer Eric MD
Chief of Div of WMNS CANCERS	$583,287	$0	$116,219	$0	$60,678	$0	$40,140	$0	$14,628	$0	$814,952	$0	$0	$0
Soiffer Robert MD
Chief of Hemotologic Malig.	$568,655	$0	$130,478	$0	$23,386	$0	$40,138	$0	$19,811	$0	$782,468	$0	$0	$0
DUVAL MELANY
SVP OF DEVELOPMENT	$615,260	$0	$80,122	$0	$2,421	$0	$56,015	$0	$17,704	$0	$771,522	$0	$0	$0
Constantine Michael MD
Milford Med Dir-Hematol Onc	$640,094	$0	$35,073	$0	$25,816	$0	$25,890	$0	$35,247	$0	$762,120	$0	$0	$0
Johnson Bruce MD
CHIEF CL RES OFF(END 9/1/21)	$546,586	$0	$104,249	$0	$28,696	$0	$38,623	$0	$22,916	$0	$741,070	$0	$0	$0
Boskey Richard S ESQ
ASST. SEC. & GC (END 12/14/20)	$536,204	$0	$93,760	$0	$22,055	$0	$40,140	$0	$28,173	$0	$720,332	$0	$0	$0
Griffin James D MD
PROFESSOR OF MEDICINE	$612,057	$0	$400	$0	$29,707	$0	$40,140	$0	$25,258	$0	$707,562	$0	$0	$0
Rollins Barrett J MD PHD
SNR ADVISOR TO PRESIDENT & CEO	$474,403	$0	$101,475	$0	$14,997	$0	$40,140	$0	$20,341	$0	$651,356	$0	$0	$0
Megdal Maria
SVP of Institute Operations	$446,318	$0	$76,080	$0	$5,142	$0	$40,140	$0	$18,452	$0	$586,132	$0	$0	$0
Stone Richard M MD
PROFESSOR OF MEDICINE	$438,387	$0	$39,937	$0	$16,452	$0	$40,140	$0	$28,301	$0	$563,217	$0	$0	$0
Liebow Elizabeth
CHIEF STRATEGY OFFICER	$393,573	$0	$69,200	$0	$1,518	$0	$37,115	$0	$28,932	$0	$530,338	$0	$0	$0
Memmott Drew
SVP RESEARCH ADMINISTRATION	$394,350	$0	$68,921	$0	$1,512	$0	$36,936	$0	$26,102	$0	$527,821	$0	$0	$0
Meyerhardt Jeffrey
CHIEF CL RES OFF(as of 9/1/21)	$400,241	$0	$20,326	$0	$7,659	$0	$38,215	$0	$35,386	$0	$501,827	$0	$0	$0
Haigis Kevin
Chief Scientific Officer	$377,414	$0	$80,400	$0	$1,854	$0	$0	$0	$3,588	$0	$463,256	$0	$0	$0
Gettleman Wendy
VP of Facilities MGMT & RE	$317,523	$0	$28,305	$0	$2,259	$0	$29,004	$0	$36,133	$0	$413,224	$0	$0	$0
Bartel Sylvia RPH MHP
VP of Pharmacy Services	$294,931	$0	$28,858	$0	$3,257	$0	$27,023	$0	$37,919	$0	$391,988	$0	$0	$0
Ebert Benjamin MD PHD
Chair of Medical Oncology	$90,547	$0	$400	$0	$109,453	$0	$6,379	$0	$1,932	$0	$208,711	$0	$0	$0

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDesc

ExplanationExplanationTxt

SCHEDULE J, PART I, LINE 4A

JAMES TERWILLIGER RECEIVED SEVERANCE PAYMENTS IN THE AMOUNT OF $360,500. THIS AMOUNT IS INCLUDED ON SCHEDULE J, PART II, COLUMN B (III). SCHEDULE J, PART I, LINE 4B The following individuals participate in 457(f) plans established by DFCI; taxable amounts are included in reportable compensation in schedule J, Part II, column (B)(iii): GLIMCHER, LAURIE, MD 66,725 BENZ, EDWARD J. JR., MD 554,876 RENEY, MICHAEL 21,127 HAHN, WILLIAM, MD, PHD 8,456 BUNNELL, CRAIG A. MD 17,750 WINER, ERIC, MD 13,496 SOIFFER, ROBERT, MD 12,170 CONSTANTINE, MICHAEL, MD 18,490 JOHNSON, BRUCE MD 10,339 BOSKEY, RICHARD S., ESQ 9,608 GRIFFIN, JAMES D., MD 16,000 ROLLINS, BARRETT J., MD, PHD 4,776 MEGDAL, MARIA 1,875 STONE, RICHARD M., MD 1,518

SCHEDULE J, PART I, LINE 7

DURING THE YEAR, THE CEO, COO, CFO, GENERAL COUNSEL AND CERTAIN KEY EMPLOYEES AND HIGHEST COMPENSATED EMPLOYEES WERE ELIGIBLE TO RECEIVE AN INCENTIVE PAYMENT, A PORTION OF WHICH HAS A NON-FIXED PAYMENT PAYABLE AT THE DISCRETION OF THE CEO AND IN THE CASE OF THE CEO, THE BOARD OF TRUSTEES, IF THE ORGANIZATION MEETS CERTAIN FINANCIAL PERFORMANCE GOALS. THE MAXIMUM NON-FIXED PORTION OF THESE INCENTIVE PAYMENTS IS BETWEEN 8% (CEO - 40% MAX, OF THAT 32% TEAM, 8% INDIVIDUAL) AND 4% (SVP - 20% MAX, OF THAT 16% TEAM AND 4% INDIVIDUAL; VP - 10% MAX, OF THAT 6% TEAM AND 4% INDIVIDUAL; and (EVP-30% MAX, OF THAT 24% TEAM AND 6% INDIVIDUAL). OTHER REPORTABLE COMPENSATION INCLUDES CURRENT YEAR VESTING AMOUNTS IN DANA-FARBER INSTITUTE'S SUPPLEMENTAL NONQUALIFIED RETIREMENT PLAN.

Schedule K IRS990ScheduleK

Tax Exempt Bonds Issues TaxExemptBondsIssuesGrp (4 entries)

Bond ReferenceBondReferenceCd	Bond Issuer EINBondIssuerEIN	Bond IssuedBondIssuedDt	Issue PriceIssuePriceAmt	PurposePurposeDesc	DefeasedDefeasedInd	On Behalf Of IssuerOnBehalfOfIssuerInd	Pool FinancingPoolFinancingInd	CUSIPCUSIPNum
Massachusetts Development Finance Agency
A	043431814	2015-08-03	$92,500,000	See Part VI	false	false	false
Massachusetts Development Finance Agency
B	043431814	2016-06-23	$281,786,480	See Part VI	false	false	false	5758XNZ00
Massachusetts Development Finance Agency
C	043431814	2019-09-03	$60,255,238	See Part VI	false	false	false	57584YVC0
MASSACHUSETTS DEVELOPMENT FINANCE AGENCY
D	043431814	2021-07-28	$57,500,000	See Part VI	false	false	false

Tax Exempt Bonds Proceeds TaxExemptBondsProceedsGrp (4 entries)

Bond ReferenceBondReferenceCd	RetiredRetiredAmt	Bond DefeasedBondDefeasedAmt	Total ProceedsTotalProceedsAmt	In Reserve FundInReserveFundAmt	Capitalized InterestCapitalizedInterestAmt	Refunding EscrowRefundingEscrowAmt	Issuance Costs From ProceedsIssuanceCostsFromProceedsAmt	Credit EnhancementCreditEnhancementAmt	Working Capital ExpendituresWorkingCapitalExpendituresAmt	Capital ExpendituresCapitalExpendituresAmt	Other Spent ProceedsOtherSpentProceedsAmt	UnspentUnspentAmt	Substantial CompletionSubstantialCompletionYr	Refunding Tax Exempt BondsRefundingTaxExemptBondsInd	Refunding Taxable BondsRefundingTaxableBondsInd	Final Allocation MadeFinalAllocationMadeInd	Adequate Books And Rec MaintAdequateBooksAndRecMaintInd
A	$0	$0	$92,500,000	$0	$0	$0	$0	$0	$0	$0	$92,500,000	$0	2015	Yes (true)	false	Yes (true)	Yes (true)
B	$0	$0	$282,863,767	$0	$1,077,287	$0	$2,486,701	$0	$0	$279,299,779	$0	$0	2019	false	false	Yes (true)	Yes (true)
C	$0	$0	$60,255,238	$0	$0	$0	$1,163,957	$0	$0	$0	$59,091,281	$0	2019	Yes (true)	false	Yes (true)	Yes (true)
D	$0	$0	$57,500,000	$0	$0	$0	$0	$0	$0	$0	$57,500,000	$0	2021	Yes (true)	false	Yes (true)	Yes (true)

Tax Exempt Bonds Private Bus Use TaxExemptBondsPrivateBusUseGrp (4 entries)

Bond ReferenceBondReferenceCd	Owning Bond Financed PropertyOwningBondFinancedPropertyInd	Any Lease ArrangementsAnyLeaseArrangementsInd	Mgmt Contract Bond Fincd PropMgmtContractBondFincdPropInd	Engage Bond Counsel ContractsEngageBondCounselContractsInd	Any Research AgreementsAnyResearchAgreementsInd	Engage Bond Counsel ResearchEngageBondCounselResearchInd	Bond Iss Meet Prvt Sec Pymt TestBondIssMeetPrvtSecPymtTestInd	Change In Use Bond Financed PropChangeInUseBondFinancedPropInd	Change In Use Bond Financed PropChangeInUseBondFinancedPropPct	Remedial Action TakenRemedialActionTakenInd	Procs Nonqualified Bond RemdtdProcsNonqualifiedBondRemdtdInd
A	false	false	Yes (true)	Yes (true)	Yes (true)	Yes (true)	false	false	0.00000	false	Yes (true)
B	false	false	false		Yes (true)	Yes (true)	false	false	0.00000	false	Yes (true)
C	false	false	Yes (true)	Yes (true)	Yes (true)	Yes (true)	false	false		false	Yes (true)
D	false	false	Yes (true)	Yes (true)	Yes (true)	Yes (true)	false	false	0.00000	false	Yes (true)

Tax Exempt Bonds Arbitrage TaxExemptBondsArbitrageGrp (4 entries)

Bond ReferenceBondReferenceCd	Form8038 T FiledForm8038TFiledInd	Rebate Not Due YetRebateNotDueYetInd	Exception To RebateExceptionToRebateInd	No Rebate DueNoRebateDueInd	Variable Rate IssueVariableRateIssueInd	Hedge Identified In Bks And RecHedgeIdentifiedInBksAndRecInd	Term Of HedgeTermOfHedgePct	Superintegrated HedgeSuperintegratedHedgeInd	Hedge TerminatedHedgeTerminatedInd	Gross Proceeds Invested In GICGrossProceedsInvestedInGICInd	Business Name Line1GICProviderName/BusinessNameLine1Txt	Gross Proceeds InvestedGrossProceedsInvestedInd	Written Proc To Monitor ReqsWrittenProcToMonitorReqsInd
Morgan Stanley
A	false	false	false	Yes (true)	Yes (true)	Yes (true)	39.8	false	false	false	0	false	Yes (true)
0
B	false	false	false	Yes (true)	false	false				false	0	false	Yes (true)
0
C	false	false	false	Yes (true)	false	false				false	0	false	Yes (true)
MORGAN STANLEY
D	false	false	Yes (true)	false	Yes (true)	Yes (true)	39.8	false	false	false	0	false	Yes (true)

Procedures Corrective Action ProceduresCorrectiveActionGrp (4 entries)

Bond ReferenceBondReferenceCd	Procedures Corrective ActionProceduresCorrectiveActionInd
A	Yes (true)
B	Yes (true)
C	Yes (true)
D	Yes (true)

Supplemental Information Detail SupplementalInformationDetail (3 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
Schedule K, PART I (BOND ISSUES):	A (F) DESCRIPTION OF PURPOSE: THE BOND ISSUE WAS USED TO REFUND SERIES L-1 BONDS ISSUED ON 5/22/2008. B (F) DESCRIPTION OF PURPOSE: THE BOND ISSUE WAS USED TO PARTIALLY COVER THE ACQUISITION AND FIT-OUT OF RESEARCH SPACE AND VIVARIUM AT THE LONGWOOD CENTER; TO PARTIALLY COVER THE REPLACEMENT OF HVAC SYSTEM AT THE SMITH BUILDING; TO COVER THE RELOCATION TO, RECONSTRUCTION AND EQUIPPING OF THE INSTITUTE'S CELL MANIPULATION CORE FACILITY; AND TO COVER THE COSTS OF BOND ISSUANCE AND INTEREST DURING THE CONSTRUCTION PERIOD AS WELL AS OTHER CAPITAL PROJECTS. C (F) DESCRIPTION OF PURPOSE: THE BOND ISSUE WAS USED TO REFUND SERIES K BONDS ISSUED ON 5/22/2008. D (F) DESCRIPTION OF PURPOSE: THE BOND ISSUE WAS USED TO REFUND SERIES L-2A BONDS ISSUED ON 7/2/2012. E (F) DESCRIPTION OF PURPOSE: THE BOND ISSUE WAS USED TO REFUND SERIES L-2B BONDS ISSUED ON 7/2/2012.
Schedule K, PART II (PROCEEDS):	B 3 THE TOTAL PROCEEDS OF $282,863,767 INCLUDE INVESTMENT EARNINGS IN THE AMOUNT OF $1,077,287.
Schedule K, PART IV (ARBITRAGE):	A 2(c) Did the following apply "No rebate due" - rebate calculation was performed in November 2020 B 2(c) Did the following apply "No rebate due" - rebate calculation was performed in November 2020 C 2(c) Did the following apply "No rebate due" - rebate calculation was performed in November 2020 D 2 (B) This issuance was refunded in 2021 and had no invested assets and qualifies for 6-month spending exception E 2 (B) This issuance was refunded in 2021 and had no invested assets and qualifies for 6-month spending exception A 4(B) NAME OF PROVIDER: MORGAN STANLEY CAPITAL SERVICES, INC. D 4(b) Name of provider: Morgan Stanley Capital Services, Inc. E 4(b) Name of provider: Morgan Stanley Capital Services, Inc.

Schedule K IRS990ScheduleK

Tax Exempt Bonds Issues TaxExemptBondsIssuesGrp

Field	Value	IRS element (for citing)
Bond Reference	A	BondReferenceCd

Issuer Name IssuerName

Field	Value	IRS element (for citing)
Business Name Line1	Massachusetts Development Finance Agency	BusinessNameLine1Txt

Field	Value	IRS element (for citing)
Bond Issuer EIN	043431814	BondIssuerEIN
CUSIP	5758XNZ00	CUSIPNum
Bond Issued	2021-07-28	BondIssuedDt
Issue Price	$35,000,000	IssuePriceAmt
Purpose	See Part VI	PurposeDesc
Defeased	false	DefeasedInd
On Behalf Of Issuer	false	OnBehalfOfIssuerInd
Pool Financing	false	PoolFinancingInd

Tax Exempt Bonds Proceeds TaxExemptBondsProceedsGrp

Field	Value	IRS element (for citing)
Bond Reference	A	BondReferenceCd
Retired	$0	RetiredAmt
Bond Defeased	$0	BondDefeasedAmt
Total Proceeds	$35,000,000	TotalProceedsAmt
In Reserve Fund	$0	InReserveFundAmt
Capitalized Interest	$0	CapitalizedInterestAmt
Refunding Escrow	$0	RefundingEscrowAmt
Issuance Costs From Proceeds	$0	IssuanceCostsFromProceedsAmt
Credit Enhancement	$0	CreditEnhancementAmt
Working Capital Expenditures	$0	WorkingCapitalExpendituresAmt
Capital Expenditures	$0	CapitalExpendituresAmt
Other Spent Proceeds	$35,000,000	OtherSpentProceedsAmt
Unspent	$0	UnspentAmt
Substantial Completion	2021	SubstantialCompletionYr
Refunding Tax Exempt Bonds	Yes (true)	RefundingTaxExemptBondsInd
Refunding Taxable Bonds	false	RefundingTaxableBondsInd
Final Allocation Made	Yes (true)	FinalAllocationMadeInd
Adequate Books And Rec Maint	Yes (true)	AdequateBooksAndRecMaintInd

Tax Exempt Bonds Private Bus Use TaxExemptBondsPrivateBusUseGrp

Field	Value	IRS element (for citing)
Bond Reference	A	BondReferenceCd
Owning Bond Financed Property	false	OwningBondFinancedPropertyInd
Any Lease Arrangements	false	AnyLeaseArrangementsInd
Mgmt Contract Bond Fincd Prop	Yes (true)	MgmtContractBondFincdPropInd
Engage Bond Counsel Contracts	Yes (true)	EngageBondCounselContractsInd
Any Research Agreements	Yes (true)	AnyResearchAgreementsInd
Engage Bond Counsel Research	Yes (true)	EngageBondCounselResearchInd
Private Bus Use By Others	0.00000	PrivateBusUseByOthersPct
Private Bus Concerning UBI	0.00000	PrivateBusConcerningUBIPct
Total Private Business Use	0.00000	TotalPrivateBusinessUsePct
Bond Iss Meet Prvt Sec Pymt Test	false	BondIssMeetPrvtSecPymtTestInd
Change In Use Bond Financed Prop	false	ChangeInUseBondFinancedPropInd
Change In Use Bond Financed Prop	0.00000	ChangeInUseBondFinancedPropPct
Remedial Action Taken	false	RemedialActionTakenInd
Procs Nonqualified Bond Remdtd	Yes (true)	ProcsNonqualifiedBondRemdtdInd

Tax Exempt Bonds Arbitrage TaxExemptBondsArbitrageGrp

Field	Value	IRS element (for citing)
Bond Reference	A	BondReferenceCd
Form8038 T Filed	false	Form8038TFiledInd
Rebate Not Due Yet	false	RebateNotDueYetInd
Exception To Rebate	Yes (true)	ExceptionToRebateInd
No Rebate Due	false	NoRebateDueInd
Variable Rate Issue	Yes (true)	VariableRateIssueInd
Hedge Identified In Bks And Rec	Yes (true)	HedgeIdentifiedInBksAndRecInd

Hedge Provider Name HedgeProviderName

Field	Value	IRS element (for citing)
Business Name Line1	Morgan Stanley	BusinessNameLine1Txt

Field	Value	IRS element (for citing)
Term Of Hedge	39.8	TermOfHedgePct
Superintegrated Hedge	false	SuperintegratedHedgeInd
Hedge Terminated	false	HedgeTerminatedInd
Gross Proceeds Invested In GIC	false	GrossProceedsInvestedInGICInd

GIC Provider Name GICProviderName

Field	Value	IRS element (for citing)
Business Name Line1	0	BusinessNameLine1Txt

Field	Value	IRS element (for citing)
Gross Proceeds Invested	false	GrossProceedsInvestedInd
Written Proc To Monitor Reqs	Yes (true)	WrittenProcToMonitorReqsInd

Procedures Corrective Action ProceduresCorrectiveActionGrp

Field	Value	IRS element (for citing)
Bond Reference	A	BondReferenceCd
Procedures Corrective Action	Yes (true)	ProceduresCorrectiveActionInd

Schedule L IRS990ScheduleL

Loans Btwn Org Interested Prsn LoansBtwnOrgInterestedPrsnGrp (4 entries)

Relationship With OrgRelationshipWithOrgTxt	Loan PurposeLoanPurposeTxt	Loan From OrganizationLoanFromOrganizationInd	Original PrincipalOriginalPrincipalAmt	Balance DueBalanceDueAmt	DefaultDefaultInd	Board Or Committee ApprovalBoardOrCommitteeApprovalInd	Written AgreementWrittenAgreementInd
Duval Melany
Employee	Housing Loan	Yes (X)	$150,000	$108,750	false	Yes (true)	Yes (true)
Ebert Benjamin
Employee	Housing Loan	Yes (X)	$500,000	$233,334	false	Yes (true)	Yes (true)
Haigis Kevin
Employee	Housing Loan	Yes (X)	$100,000	$85,833	false	Yes (true)	Yes (true)
Liebow Elizabeth
Employee	Housing Loan	Yes (X)	$150,000	$143,750	false	Yes (true)	Yes (true)

Field	Value	IRS element (for citing)
Total Balance Due	$571,667	TotalBalanceDueAmt

Schedule M IRS990ScheduleM

Field	Value	IRS element (for citing)
Works Of Art		WorksOfArtGrp
Art Historical Treasures		ArtHistoricalTreasuresGrp
Art Fractional Interest		ArtFractionalInterestGrp
Books And Publications		BooksAndPublicationsGrp

Clothing And Household Goods ClothingAndHouseholdGoodsGrp

Field	Value	IRS element (for citing)
Non Cash Checkbox	Yes (X)	NonCashCheckboxInd
Noncash Contributions Rpt F990	$1,388,854	NoncashContributionsRptF990Amt
Method Of Determining Revenues	Letter from Donor	MethodOfDeterminingRevenuesTxt

Field	Value	IRS element (for citing)
Cars And Other Vehicles		CarsAndOtherVehiclesGrp
Boats And Planes		BoatsAndPlanesGrp
Intellectual Property		IntellectualPropertyGrp

Securities Publicly Traded SecuritiesPubliclyTradedGrp

Field	Value	IRS element (for citing)
Non Cash Checkbox	Yes (X)	NonCashCheckboxInd
Contribution	260	ContributionCnt
Noncash Contributions Rpt F990	$18,531,068	NoncashContributionsRptF990Amt
Method Of Determining Revenues	Fair Market Value	MethodOfDeterminingRevenuesTxt

Field	Value	IRS element (for citing)
Securities Closely Held Stock		SecuritiesCloselyHeldStockGrp
Secur Prtnrshp Trust Intrsts		SecurPrtnrshpTrustIntrstsGrp
Securities Miscellaneous		SecuritiesMiscellaneousGrp
Qualified Contrib Hist Struct		QualifiedContribHistStructGrp
Qualified Contrib Other		QualifiedContribOtherGrp
Real Estate Residential		RealEstateResidentialGrp
Real Estate Commercial		RealEstateCommercialGrp
Real Estate Other		RealEstateOtherGrp
Collectibles		CollectiblesGrp

Food Inventory FoodInventoryGrp

Field	Value	IRS element (for citing)
Non Cash Checkbox	Yes (X)	NonCashCheckboxInd
Contribution	7	ContributionCnt
Noncash Contributions Rpt F990	$93,596	NoncashContributionsRptF990Amt
Method Of Determining Revenues	Letter from Donor	MethodOfDeterminingRevenuesTxt

Field	Value	IRS element (for citing)
Drugs And Medical Supplies		DrugsAndMedicalSuppliesGrp
Taxidermy		TaxidermyGrp
Historical Artifacts		HistoricalArtifactsGrp
Scientific Specimens		ScientificSpecimensGrp
Archaeological Artifacts		ArchaeologicalArtifactsGrp

Other Non Cash Contri Table OtherNonCashContriTableGrp

Field	Value	IRS element (for citing)
Non Cash Checkbox	Yes (X)	NonCashCheckboxInd
Desc	Miscellaneous	Desc
Contribution	9	ContributionCnt
Noncash Contributions Rpt F990	$513,823	NoncashContributionsRptF990Amt
Method Of Determining Revenues	Letter from Donor	MethodOfDeterminingRevenuesTxt

Field	Value	IRS element (for citing)
Any Property That Must Be Held	false	AnyPropertyThatMustBeHeldInd
Review Process Unusual NC Gifts	Yes (true)	ReviewProcessUnusualNCGiftsInd
Third Parties Used	false	ThirdPartiesUsedInd

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	SCHEDULE M, PART I, COLUMN (B)	FormAndLineReferenceDesc
Explanation	DANA-FARBER CANCER INSTITUTE, INC. IS REPORTING THE NUMBER OF CONTRIBUTIONS RECEIVED. SCHEDULE M, PART I, LINE 33 DANA-FARBER CANCER INSTITUTE, INC. RECEIVED DONATIONS OF ART, BOOKS, AND OTHER GOODS THAT IT DISPLAYS IN ITS PROPERTIES. THESE GOODS HAVE VALUES THAT ARE EITHER NOMINAL OR ARE NOT READILY DETERMINABLE AND ARE, THEREFORE, NOT INCLUDED AS REVENUE.	ExplanationTxt

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (8 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
FORM 990, PART I, LINE 1	THE MISSION OF DANA-FARBER CANCER INSTITUTE, INC. (DFCI) IS TO PROVIDE EXPERT, COMPASSIONATE, AND EQUITABLE CARE TO CHILDREN, ADULTS, AND THEIR FAMILIES, WHILE ADVANCING THE UNDERSTANDING, DIAGNOSIS, TREATMENT, CURE, AND PREVENTION OF CANCER AND RELATED DISEASES. FORM 990, PART III, LINE 1 The Mission of DFCI is to provide expert, compassionate, and equitable care to children, adults, and their families, while advancing the understanding, diagnosis, treatment, cure, and prevention of cancer and related diseases. We train new generations of clinicians and scientists, disseminate innovative patient therapies and scientific discoveries around the world, and reduce the impact of cancer, while at all times maintaining a focus on those communities who have been historically marginalized. FORM 990, PART III, LINE 4A CLINICAL CARE As one of the leading cancer centers in the world, DFCI provides compassionate, comprehensive, and personalized care to adults and children with cancer, blood disorders, and related diseases. In fiscal year 2021, our expert clinicians and caregivers at our specialized treatment centers worked together to deliver the latest therapies to our patients through 1,436 inpatient admissions, 364,577 outpatient MD visits, and 188,242 infusion treatments. Since its founding in 1947 by Sidney Farber, MD, Dana-Farber has followed his vision for a cancer center that is just as dedicated to discoveries in cancer research as it is to delivering expert, compassionate care. Dana-Farber is a founding member of Dana-Farber/Harvard Cancer Center and one of 51 NCI-designated Comprehensive Cancer Centers in the UNITED STATES. Dana-Farber is the only hospital ranked in the top four nationally by U.S. News and World Report in both adult and pediatric cancer care. In 2021, we offered more than 1,100 clinical trials. FORM 990, PART III, LINE 4B RESEARCH Scientific work at Dana-Farber is based on the premise that basic and clinical investigation are complementary and reinforcing activities. To encourage this cross-pollination of ideas, the Institute has developed an organizational framework that fosters collaborations among investigators from different disciplines. The result is an intense scientific impact on a group of diseases that continue to represent one of humanity's greatest health challenges. Some recent advances include: Immunotherapy Combination Found Effective in Non-small Cell Lung Cancer: A combination of two drugs that open the floodgates to an immune system attack on cancer curtailed tumor growth in some patients with non-small cell lung cancer that was resistant to a single immunotherapy agent, A CLINICAL TRIAL LED BY DANA-FARBER INVESTIGATORS SHOWED. Cellular Source of Barrett's Esophagus Identified: In two studies, Dana-Farber scientists demonstrated that Barrett's esophagus - a potential precursor of esophageal adenocarcinoma - does not involve esophageal cells turning into intestinal cells, as had long been thought, but of stomach cells adopting some of the characteristics of intestinal cells. Immunotherapy Combination Found Beneficial in Advanced Melanoma: A combination of two drugs that target different proteins on immune system T cells kept advanced melanoma in check significantly longer than one of the drugs alone in a clinical trial co-led by Dana-Farber scientists. Drug Combination Can Keep Chronic Leukemia in Remission in Young Patients: Young patients with chronic lymphocytic leukemia can enjoy long remissions on the drug ibrutinib and chemotherapy, but must stay on ibrutinib indefinitely to keep the cancer in remission, Dana-Farber researchers found in a clinical trial. Vaccination Protects Against COVID-19 in Patients with Myeloma: For patients with multiple myeloma, vaccination against COVID-19 provides some protection against coronavirus infection, but to a far lower degree than the general population of cancer survivors, Dana-Farber investigators found. Targeted Drug Combination Shows Unprecedented Activity in Some Brain Tumors: A combination of two targeted cancer drugs - dabrafenib and trametinib - showed unprecedented, "clinically meaningful" activity in patients with highly malignant brain tumors that carried a rare genetic mutation, a clinical trial led by Dana-Farber investigators showed. Discovery May Lead to Expanded Donor Pool for Stem Cell Transplants: Dana-Farber researchers found that in most cases, stem cell transplants from donors with clonal hematopoiesis, an asymptomatic blood condition, are safe and effective. Venetoclax Can Benefit Patients with Waldenstrom Macroglobulinemia: In a clinical trial led by Dana-Farber investigators, more than 80% of patients with Waldenstrom macroglobulinemia had a "major" response to a two-year course of the drug venetoclax with generally manageable side effects. Older and Younger Patients with Metastatic Colorectal Cancer Have Similar Survival: Even though young patients with metastatic colorectal cancer tend to be more fit and receive more intensive treatment than older patients, both groups survive for roughly the same amount of time, Dana-Farber researchers reported. Young Women Who Undergo Mastectomy Report Lower Quality of Life: Even as more young women with breast cancer opt to have mastectomies, many experience a persistent decline in their sexual and psychosocial well-being following the procedure, research by Dana-Farber investigators shows. Antibody-Drug Conjugate Impressive in Patients with a Form of Non-small Cell Lung Cancer: In an international clinical trial led by Dana-Farber investigators, more than half of patients with non-small cell lung cancer harboring a mutation in the HER2 gene had their tumors stop growing or shrink for an extended time after treatment with a drug consisting of a chemotherapy agent linked to an antibody. Vitamin D May Protect Against Young-Onset Colorectal Cancer: Consuming higher amounts of Vitamin D - mainly from dietary sources - may help protect against developing young-onset colorectal cancer or precancerous colon polyps, researchers at Dana-Farber and other institutions reported in the first study to show such an association. Pain Management Worsening for Patients with Terminal Cancer: In a sign that pain management for patients dying of cancer is worsening, a study by Dana-Farber investigators found a sharp decline in opioid access among these patients over a recent 10-year period, even as many more of them turned to hospital emergency rooms for pain treatment. Cancer Screenings Rebounded After COVID-related Decline: The numbers of cancer screening tests rebounded sharply in the last quarter of 2020, following a dramatic decline in the first months of the COVID-19 pandemic, at one large hospital system in the Northeastern United States, a study by Dana-Farber researchers showed. Antibiotic Found to Kill Tumor Cells with DNA-repair Glitch: Novobiocin, an antibiotic developed in the 1950s and largely supplanted by newer drugs, effectively targets, and kills cancer cells with a common genetic defect, research by Dana-Farber scientists showed. The findings spurred investigators to open a clinical trial of the drug for patients whose tumors carry the abnormality. Red Meat Consumption May Promote DNA Damage Associated with Colorectal Cancer: Genetic mutations indicative of DNA damage were associated with high red meat consumption, and increased cancer-related mortality in patients with colorectal cancer, a study led by Dana-Farber researchers found. Immunotherapy Drug Delays Kidney Cancer Recurrence: Treatment with the immunotherapy drug pembrolizumab after kidney cancer surgery prolonged the period in which patients lived without a recurrence of the cancer among patients at high risk of such recurrence, Dana-Farber researchers found. Level of Chromosomal Abnormality in Non-small Cell Lung Cancer May Predict Response to Immunotherapy: Patients with non-small cell lung cancer whose cancer cells have low levels of aneuploidy - an abnormal number of chromosomes - tend to respond better to immune checkpoint inhibitor drugs than patients with higher levels, Dana-Farber researchers reported. New Targeted Drug Shown Effective in Patients with a Form of Uterine Cancer: In its first clinical trial in patients with uterine serous carcinoma, a hard-to-treat form of uterine cancer, the targeted drug adavosertib, which subjects tumor cells to extensive DNA damage caused tumors to shrink in nearly one-third of patients, Dana-Farber investigators reported.
FORM 990, PART III, LINE 4C	COMMUNITY BENEFITS The role of Dana-Farber's Community Benefits Office is to support the institute's goal to reduce cancer risk among medically underserved populations. To that end, we work with city and state health departments, community partners, and Boston-based coalitions to assess and monitor the needs of local residents with respect to cancer control. We are on the front lines of supporting and collaborating on programs designed to eliminate disparities in breast, colon, skin, and prostate cancer; educate diverse populations about tobacco cessation, human papillomavirus (HPV) prevention and screening, and clinical trials; and strengthen the support system for medically underserved populations. In short, we are committed to making Dana-Farber's care and research findings more accessible to everyone within and outside its walls. In FY 2021: A total of 1,512 individuals were reached overall through 17 community education, outreach, and screening events. program volumes have continued to be impacted by the covid-19 pandemic. The Community Benefits Office has continued to pivot to adapt to challenges related to the ongoing COVID-19 pandemic. In particular, the Community Benefits Office has continued to provide education virtually by leveraging the online platforms of community partners such as Union Capital Boston. In addition, Dana-Farber worked closely with an allocations committee to launch the Institute's determination of need community health initiative funding process virtually. Through this process, Dana-Farber awarded the first round of funding for its access to services awards, aimed at ensuring all residents, particularly those at higher risk for developing cancer and other chronic conditions, have access to coordinated and equitable health and support services. Programmatic highlights are as follows: Dana-Farber's mammography services provided 1,774 mammograms in the van and at the mammography suite at Whittier Street Health Center in Roxbury. Dana-Farber's Sun Safety program developed a COVID-19 protocol to ensure that adequate health and safety measures were followed at each screening event. In FY 2021, 11 in-person sun safety screening events were held with added health and safety measures and approval from local health departments. 484 participants were screened by a dermatologist and 133 people were referred for follow-up appointments. 65 participants were referred for a biopsy. The majority of biopsy recommendations were due to a presumptive diagnosis of basal cell carcinoma, squamous cell carcinoma or melanoma. The Tobacco Treatment program received 96 referrals and provided 125 individual tobacco cessation counseling sessions to 41 patients. 36 participants were able to reduce their total number of cigarettes smoked per day, and 10 of these reported being able to quit completely. In FY21 the Tobacco Treatment program received a grant from Friends of Dana-Farber Cancer Institute. The funds were used to provide financial incentives for patients enrolled in the smoking cessation program to encourage individuals to reduce their tobacco usage and quit smoking. Dana-Farber continues to partner with Team Maureen to lead the statewide Massachusetts HPV Coalition. This year, the Coalition's oral HPV task force launched the second edition of their dental toolkit for providers and patients in 7 languages. Dana-Farber also continues to play a leading role in the Annual HPV-Related Cancer Summit. Approximately 105 medical and dental providers, public health professionals, and community advocates attended the FY21 summit on the latest HPV research and best practices. Dana-Farber awarded the first round of funding for its access to services grants to 12 nonprofit organizations in Greater Boston to support long-lasting community health improvement and boost linkages to existing health and support services in the region. Dana-Farber committed approximately $1 million dollars to the healthy neighborhoods equity fund to address housing needs in Greater Boston. Dana-Farber partnered with Union Capital Boston and the Dana-Farber/Harvard Cancer Center to host 4 cancer awareness resource nights focused on breast and colorectal cancer screening, the HPV vaccine, cancer clinical trials, and cancer survivorship, engaging over 800 community residents virtually. These events featured an education session on a cancer-related topic, survivor testimony, and Q&A sessions with audience members. Dana-Farber launched a new partnership with myhealthfair.org to increase virtual education and outreach with the local Spanish-speaking community. In FY21, Dana-Farber was able to provide video and written educational materials, as well as promote sun safety and mammography van events. FORM 990, PART VI, SECTION A, LINE 2 FAMILY OR BUSINESS RELATIONSHIP FAMILY RELATIONSHIP: JOHN O'CONNOR AND LAURA SEN BUSINESS RELATIONSHIP: RICHARD LUBIN, CHRISTOPHER HADLEY, AND JANE BROCK-WILSON BUSINESS RELATIONSHIP: JOSH BEKENSTEIN, ANDREW KAPLAN, AND NANCY LOTANE BUSINESS RELATIONSHIP: PHILLIP GROSS AND DEMOND MARTIN Business Relationship: Andrew Janower And Michael Eisenson Form 990, Part VI, SECTION B, Line 11B PROCESS USED TO REVIEW THE FORM 990 THE DANA-FARBER CANCER INSTITUTE TAX DEPARTMENT PROVIDES ALL FINANCIAL ANALYSIS AND OTHER INFORMATION TO BE INCLUDED ON THE TAX RETURN TO ITS EXTERNAL TAX PREPARER, ERNST & YOUNG LLP, WHICH PREPARES THE DRAFT RETURN. THE DRAFT RETURN IS THEN REVIEWED BY THE DFCI TAX MANAGER, AS WELL AS THE DFCI OFFICE OF GENERAL COUNSEL AND SENIOR MANAGEMENT, BEFORE IT IS SUBMITTED FOR DFCI AUDIT COMMITTEE REVIEW. AFTER THE AUDIT COMMITTEE REVIEWS THE TAX RETURN, AN ELECTRONIC MESSAGE IS SENT TO ALL BOARD MEMBERS WITH A SECURE LINK TO THE TAX RETURN. THE BOARD HAS THE OPPORTUNITY TO REVIEW THE RETURN AND BRING ANY ISSUES TO THE ATTENTION OF THE APPROPRIATE EXECUTIVE MANAGEMENT INDIVIDUALS. A FINAL VERSION OF THE FORM IS APPROVED BY THE CFO AND FILED ELECTRONICALLY BY ERNST & YOUNG LLP WITH THE IRS.
FORM 990, PART VI, SECTION B, LINE 12C	MONITORING & ENFORCEMENT OF CONFLICT OF INTEREST POLICY DFCI MONITORS AND ENFORCES COMPLIANCE WITH THE DFCI CONFLICT-OF-INTEREST POLICIES FOR BOARD OFFICERS, TRUSTEES, AND KEY EMPLOYEES ("COVERED PERSONS"). THE OFFICE OF THE GENERAL COUNSEL ANNUALLY DISTRIBUTES A CONFLICT OF INTEREST QUESTIONNAIRE AND CONFIDENTIALITY STATEMENT REQUIRING ALL COVERED PERSONS TO DISCLOSE INTERESTS, ROLES, AND ACTIVITIES THAT COULD GIVE RISE TO A POTENTIAL OR ACTUAL CONFLICT WITH THE INTERESTS OF DFCI. IF A TRUSTEE FAILS TO COMPLETE THE ANNUAL STATEMENT, THE CHAIR OF THE GOVERNANCE COMMITTEE MAY TAKE ACTIONS TO SUSPEND THE TRUSTEE OR CAUSE REMOVAL. DFCI REQUIRES COVERED PERSONS TO COMPLETE THE STATEMENT UPON INITIAL APPOINTMENT TO A COVERED OFFICE AND TO UPDATE THEIR DISCLOSURES ON A CONTINUING BASIS WHENEVER A COVERED PERSON BECOMES AWARE OF A NEW OR PREVIOUSLY UNDISCLOSED INTEREST. THE OFFICE OF GENERAL COUNSEL COMPARES THE DISCLOSURES TO INSTITUTIONAL INFORMATION IN ORDER TO IDENTIFY POTENTIAL OR ACTUAL CONFLICTS OF INTEREST. THE GOVERNANCE COMMITTEE OF THE DFCI BOARD OF TRUSTEES REVIEWS DISCLOSURES AND WORKS WITH THE GENERAL COUNSEL TO ADDRESS ISSUES THAT MAY ARISE. THE GOVERNANCE COMMITTEE IS RESPONSIBLE TO BRING MAJOR ISSUES RELATED TO THE CONFLICT OF INTEREST POLICY TO THE EXECUTIVE COMMITTEE AND THE ENTIRE BOARD IF DEEMED NECESSARY. THE BOARD'S CONFLICTS OF INTEREST OVERSIGHT COMMITTEE REVIEWS AND, WHEN APPROPRIATE, INSTITUTES WRITTEN MANAGEMENT PLANS TO MANAGE CONFLICTS OF INTEREST PRESENTED BY INTERESTS OF CERTAIN EXECUTIVE OFFICERS AND CERTAIN TRUSTEE INVESTMENT INTERESTS. A PROPOSED ARRANGEMENT CREATING A CONFLICT OF INTEREST MAY BE APPROVED IF APPROPRIATE STEPS ARE TAKEN TO ENSURE THAT DFCI MAKES A DECISION IN AN OBJECTIVE AND FAIR MANNER CONSISTENT WITH THE HIGHEST ETHICAL AND LEGAL STANDARDS. SUCH STEPS INCLUDE RECUSAL OF THE COVERED PERSON WITH A CONFLICT OF INTEREST FROM NEGOTIATIONS OR DISCUSSIONS ON BEHALF OF DFCI OR THE ENTITY WITH WHICH DFCI IS DOING BUSINESS AND FROM BOARD OR DFCI MANAGEMENT DISCUSSIONS OF SUCH ARRANGEMENT.
FORM 990, PART VI, SECTION B, LINE 15A	PROCESS FOR DETERMINING COMPENSATION OF PRESIDENT PER DFCI'S EXECUTIVE COMPENSATION PHILOSOPHY, ANNUALLY THE COMPENSATION COMMITTEE OF THE BOARD OF TRUSTEES REVIEWS THE PRESIDENT'S (DFCI'S CHIEF EXECUTIVE OFFICER) PERFORMANCE AND MAKES A RECOMMENDATION REGARDING COMPENSATION TO THE EXECUTIVE COMMITTEE. THE EXECUTIVE COMMITTEE ACTS ON THE RECOMMENDATION. TO ENSURE COMPLIANCE WITH THE PHILOSOPHY, THE COMPENSATION COMMITTEE BI-ANNUALLY COMMISSIONS AN INDEPENDENT REVIEW BY A THIRD PARTY EXECUTIVE COMPENSATION CONSULTANT TO COMPARE SUCH COMPENSATION WITH THAT OF OTHER SIMILARLY SITUATED INDIVIDUALS IN THE HEALTHCARE FIELD IN AND OUTSIDE OF THE REGION. THE DECISION OF THE EXECUTIVE COMMITTEE IS REPORTED TO THE FULL BOARD. THE BOARD COMPLETED THIS PROCESS AS OF SEPTEMBER 2020.
FORM 990, PART VI, SECTION B, LINE 15B	PROCESS FOR DETERMINING COMPENSATION OF OFFICERS AND KEY EMPLOYEES PER DFCI'S EXECUTIVE COMPENSATION PHILOSOPHY, ANNUALLY THE DFCI PRESIDENT REVIEWS THE PERFORMANCE OF OFFICERS AND KEY EMPLOYEES. THE PRESIDENT MAKES A RECOMMENDATION AS TO THE COMPENSATION OF THOSE INDIVIDUALS WHO ARE DISQUALIFIED PERSONS OF DFCI TO THE COMPENSATION COMMITTEE OF THE BOARD OF TRUSTEES. THE COMPENSATION COMMITTEE APPROVES COMPENSATION FOR THOSE INDIVIDUALS BASED ON THAT RECOMMENDATION. FOR KEY EMPLOYEES WHO ARE NOT DISQUALIFIED PERSONS, THE PRESIDENT REPORTS TO THE COMPENSATION COMMITTEE OF THE BOARD OF TRUSTEES ON HER DETERMINATION OF COMPENSATION FOR THOSE INDIVIDUALS. TO ENSURE COMPLIANCE WITH THE PHILOSOPHY, THE PRESIDENT AND COMPENSATION COMMITTEE BI-ANNUALLY RECEIVES THE REPORT OF AN INDEPENDENT REVIEW BY A THIRD PARTY EXECUTIVE COMPENSATION CONSULTANT TO COMPARE SUCH COMPENSATION WITH THAT OF OTHER SIMILARLY SITUATED INDIVIDUALS IN THE HEALTHCARE FIELD IN AND OUTSIDE OF THE REGION. THE APPROVAL OF THE COMPENSATION COMMITTEE IS REPORTED TO THE EXECUTIVE COMMITTEE OF THE BOARD OF TRUSTEES AND TO THE FULL BOARD. THE BOARD COMPLETED THIS PROCESS AS OF SEPTEMBER 2020.
FORM 990, PART VI, SECTION C, LINE 19	AVAILABILITY OF GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS TO THE PUBLIC. GOVERNING DOCUMENTS THE GOVERNING DOCUMENTS ARE AVAILABLE UPON REQUEST. THE GOVERNING DOCUMENTS ARE ALSO AVAILABLE TO THE PUBLIC ON THE SECRETARY OF THE COMMONWEALTH'S WEBSITE. CONFLICT OF INTEREST POLICY DANA-FARBER CANCER INSTITUTE'S BOARD OF TRUSTEES CONFLICT OF INTEREST POLICY IS AVAILABLE UPON REQUEST. FINANCIAL STATEMENTS THE ORGANIZATION USES THE SERVICES OF DIGITAL ASSURANCE CERTIFICATION LLC (DAC) TO REPORT ANNUAL AUDITED FINANCIAL STATEMENTS AND OTHER RELEVANT ORGANIZATIONAL INFORMATION AS REQUIRED BY CERTAIN REGULATORY AND TAX LAWS. DAC IS A WEBSITE (WWW.DACBOND.COM) FREE TO THE PUBLIC THAT PUBLISHES TAX-EXEMPT BOND ISSUERS' FINANCIAL AND LEGAL DOCUMENTS SUCH AS THE AUDITED FINANCIAL STATEMENTS. FISCAL YEAR 2016 THROUGH THE LATEST ISSUE DATE OF THE AUDITED FINANCIAL STATEMENTS FOR DANA-FARBER CANCER INSTITUTE, INC. CAN BE FOUND ON THE DAC WEBSITE. ANNUAL AUDITED FINANCIAL STATEMENTS FROM FISCAL YEAR 1998 THROUGH FISCAL YEAR 2015 ARE AVAILABLE UPON REQUEST.
FORM 990, PART VII, SECTION B, LINE 1	THE AMOUNT PAID TO WALSH BROTHERS, INC. INCLUDED COSTS FOR BUILDING SERVICES AND MATERIALS. HOWEVER, THE ORGANIZATION WAS UNABLE TO OBTAIN INFORMATION TO BREAKOUT THE EXACT AMOUNT FOR MATERIAL COSTS.
FORM 990, PART XI, LINE 9	OTHER CHANGES IN NET ASSETS CHANGE IN INTEREST IN ASSETS HELD BY AFFILIATES $ 576,115,403 CHANGE IN VALUE OF SWAP AGREEMENT $ 13,721,943 PENSION ADJUSTMENT $ 7,027,782 ---------------------- TOTAL OTHER CHANGES IN NET ASSETS $ 596,865,128

Schedule R IRS990ScheduleR

Id Disregarded Entities IdDisregardedEntitiesGrp (2 entries)

Address Line1USAddress/AddressLine1Txt	CityUSAddress/CityNm	State AbbreviationUSAddress/StateAbbreviationCd	ZIPUSAddress/ZIPCd	EINEIN	Primary ActivitiesPrimaryActivitiesTxt	Legal Domicile StateLegalDomicileStateCd	Total IncomeTotalIncomeAmt	End Of Year AssetsEndOfYearAssetsAmt	Business Name Line1DirectControllingEntityName/BusinessNameLine1Txt
Dana-Farber Global Oncology LLC
450 BROOKLINE AVENUE BP418	BOSTON	MA	02215	851914853	Int. Oncology	MA	-$305,116	$3,626,918	DFCI
BINNEY STREET CAPITAL FUND LLC
450 BROOKLINE AVE BP418	BOSTON	MA	02215		INVESTMENTS	DE	-$457,498	$499,998	DFI

Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp (7 entries)

Address Line1USAddress/AddressLine1Txt	CityUSAddress/CityNm	State AbbreviationUSAddress/StateAbbreviationCd	ZIPUSAddress/ZIPCd	EINEIN	Primary ActivitiesPrimaryActivitiesTxt	Legal Domicile StateLegalDomicileStateCd	Exempt Code SectionExemptCodeSectionTxt	Public Charity StatusPublicCharityStatusTxt	Business Name Line1DirectControllingEntityName/BusinessNameLine1Txt	Controlled OrganizationControlledOrganizationInd
Dana-Farber Inc
450 Brookline Avenue BP418	Boston	MA	02215	043102433	INVEST. MGMT.	MA	501(c)(3)	12A, TYPE I	DFCI	Yes (true)
Dana-Farber Trust Inc
450 Brookline Avenue BP418	Boston	MA	02215	300195757	DFCI RE HOLDI	MA	501(c)(3)	12a, type 1	DFCI	Yes (true)
DANA-FARBERMASS GEN BRIGHAM CANCER CARE
450 Brookline Avenue BP418	Boston	MA	02215	043320640	ONC. RESEARCH	MA	501(c)(3)	12A, type 1	NA	false
RMSA Trust
450 Brookline Avenue BP418	Boston	MA	02215	562656539	VEBA TRUST	MA	501(c)(9)	N/A	DFCI	Yes (true)
Friends of Dana-Farber Cancer Institute
450 BROOKLINE AVENUE BP418	Boston	MA	02215	371613621	Fundraising	MA	501(c)(3)	12A, Type I	DFCI	Yes (true)
Dana-FarberChildren's Hosp Cancer Care
450 Brookline Avenue BP418	Boston	MA	02215	043554536	Pediatric Onc	MA	501(c)(3)	12A, type I	NA	false
Dana-Farber Cancer Care Network Inc
450 Brookline Avenue BP418	Boston	MA	02215	465138314	ONCOLOGY CARE	MA	501(c)(3)	10	DFCI	Yes (true)

Id Related Org Txbl Partnership IdRelatedOrgTxblPartnershipGrp

Related Organization Name RelatedOrganizationName

Field	Value	IRS element (for citing)
Business Name Line1	MGB DF INTL LLC	BusinessNameLine1Txt

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	399 Revolution Dr Ste 645	AddressLine1Txt
City	SOMERVILLE	CityNm
State Abbreviation	MA	StateAbbreviationCd
ZIP	02145	ZIPCd

Field	Value	IRS element (for citing)
EIN	871595882	EIN
Primary Activities	INTL. CONSULTING	PrimaryActivitiesTxt
Legal Domicile State	DE	LegalDomicileStateCd
Predominant Income Type	NONE	PredominantIncomeTypeTxt
Share Of Total Income	$0	ShareOfTotalIncomeAmt
Share Of EOY Assets	$0	ShareOfEOYAssetsAmt
Disproportionate Allocations	false	DisproportionateAllocationsInd
UBI Code V	$0	UBICodeVAmt
General Or Managing Partner	false	GeneralOrManagingPartnerInd
Ownership	0.50000	OwnershipPct

Field	Value	IRS element (for citing)
Receipt Of Int Annts Rnts Rylts	false	ReceiptOfIntAnntsRntsRyltsInd
Gift Grnt Or Cap Contri To Oth Org	false	GiftGrntOrCapContriToOthOrgInd
Gift Grnt Cap Contri From Oth Org	Yes (true)	GiftGrntCapContriFromOthOrgInd
Loans Or Guarantees To Other Org	false	LoansOrGuaranteesToOtherOrgInd
Loans Or Guarantees From Oth Org	false	LoansOrGuaranteesFromOthOrgInd
Div Related Organization	false	DivRelatedOrganizationInd
Asset Sale To Other Org	false	AssetSaleToOtherOrgInd
Asset Purchase From Other Org	false	AssetPurchaseFromOtherOrgInd
Asset Exchange	false	AssetExchangeInd
Rental Of Facilities To Oth Org	false	RentalOfFacilitiesToOthOrgInd
Rental Of Fclts From Oth Org	false	RentalOfFcltsFromOthOrgInd
Perform Of Services For Oth Org	false	PerformOfServicesForOthOrgInd
Perform Of Services By Other Org	Yes (true)	PerformOfServicesByOtherOrgInd
Sharing Of Facilities	false	SharingOfFacilitiesInd
Paid Employees Sharing	Yes (true)	PaidEmployeesSharingInd
Reimbursement Paid To Other Org	Yes (true)	ReimbursementPaidToOtherOrgInd
Reimbursement Paid By Other Org	false	ReimbursementPaidByOtherOrgInd
Transfer To Other Org	Yes (true)	TransferToOtherOrgInd
Transfer From Other Org	Yes (true)	TransferFromOtherOrgInd

Transactions Related Org TransactionsRelatedOrgGrp (7 entries)

Transaction TypeTransactionTypeTxt	InvolvedInvolvedAmt	Method Of Amount DeterminationMethodOfAmountDeterminationTxt
DANA-FARBER INC
R	$176,705,066	CASH
DANA-FARBER INC
S	$411,520,290	CASH
FRIENDS OF DANA-FARBER CANCER INSTITUTE INC
O	$295,612	ACTUAL EXP
FRIENDS OF DANA-FARBER CANCER INSTITUTE INC
C	$637,605	CASH
RMSA TRUST
R	$286,572	CASH
DANA-FARBER CANCER CARE NETWORK INC
M	$8,928,102	COST
DANA-FARBER CANCER CARE NETWORK INC
P	$11,276,983	COST